MOLECULAR MECHANISMS OF THE DNA DAMAGE RESPONSE INDUCED DURING PARVOVIRUS INFECTION by Luo, Yong
 
 
 
MOLECULAR MECHANISMS OF THE DNA DAMAGE RESPONSE INDUCED 
DURING PARVOVIRUS INFECTION 
BY 
Yong Luo 
Submitted to the graduate degree program in Microbiology, Molecular Genetics and 
Immunology and the Graduate Faculty of the University of Kansas in partial fulfillment of the 
requirements for the degree of Doctor of Philosophy. 
 
 
        Dissertation Committee:  
 
 
_____________________________  
Jianming Qiu, Ph.D., Chairperson  
 
 
_____________________________  
Nikki Cheng, Ph.D.  
 
 
_____________________________  
Mohammad Ayoub Mir, Ph.D.  
 
 
_____________________________  
Joe Lutkenhaus, Ph.D.  
 
 
_____________________________  
Edward Stephens, Ph.D.  
 
 
_____________________________  
Charlotte Vines, Ph.D.  
 
 
 
 
                                                     Date defended: November 14th 2012                       
ii 
 
 
 
 
The Dissertation Committee for Yong Luo 
certifies that this is the approved version of the following dissertation: 
 
 
 
MOLECULAR MECHANISMS OF THE DNA DAMAGE RESPONSE INDUCED 
DURING PARVOVIRUS INFECTION 
 
 
 
 
 
 
      ________________________________ 
Jianming Qiu, Ph.D, Chairperson.  
 
 
                                                    Date approved: December 4th, 2012
iii 
Abstract 
DNA damage response (DDR) is a critical safeguarding system to protect genomic 
stability and integrality through a cascade of phosphorylation events of three PI-3-kinase-like 
kinases: ATM (ataxia telangiectasia mutated), ATR (ATM and Rad3 related), and DNA-PKcs 
(DNA-dependent protein kinase catalytic subunit). Although numerous studies have established 
that the DDR is mainly triggered by exposure to ultraviolet, ionizing irradiation and chemical 
treatment, which introduce DNA breaks into genomes, accumulating evidence has demonstrated 
that infections of most DNA viruses and some retroviruses are able to induce a DDR, which plays 
a critical role in the life cycle of the viruses. 
Parvoviruses are small, non-enveloped and single-stranded DNA (ssDNA) viruses, and 
cause highly contagious diseases that are sometimes fatal in humans and animals. Parvoviral 
genomes are usually 5-6kb, and are flanked by two inverted terminal repeats. Two parvoviruses, 
minute virus of canines (MVC), a model virus for the study of human bocavirus that causes 
respiratory tract diseases in children worldwide, and human parvovirus B19 (B19V), a causative 
agent of several human diseases including bone marrow failure diseases and hydrops fetalis, 
were used in our study to probe the mechanisms of parvovirus infection-induced DDR. We found 
infection of both MVC and B19V triggers phosphorylation of the DDR upstream kinases in their 
host cells, and MVC mainly activates the ATM signaling pathway, while B19V activates the ATR 
signaling pathway. Moreover, we identified that inhibition of the kinases through inhibitor 
treatment or small interfering RNA knockdown significantly blocks viral DNA replication. These 
results indicate that, in contrast to turn on the protection effects of the DDR, parvovirus activates 
and hijacks the cellular DDR machinery for viral DNA amplification. 
Following these studies, we next explored the mechanism by which the ATM signaling 
pathway contributes to MVC DNA replication. We discovered that MVC infection induces an 
intra-S phase arrest to block cellular DNA replication and to hijack the DNA replication machinery 
for viral DNA synthesis. The intra-S phase arrest is dependent on ATM signaling. Moreover, we
iv 
identified SMC1 (structural maintenance of chromosomes 1) as the key regulator of the viral 
infection-induced intra-S phase arrest. Either knockdown of SMC1 or complementation with a 
dominant-negative SMC1 mutant blocked both the intra-S phase arrest and viral DNA replication. 
Finally, we found that the intra-S phase arrest induced during MVC infection is neither caused by 
damaged host cellular DNA nor by viral proteins, but by replicating viral genomes, which are 
physically associated with the DNA damage sensor, the Mre11-Rad50-Nbs1 (MRN) complex. 
Taken together, by using MVC and B19V as model organisms, we have probed the basic 
mechanism of the DDR induced during parvovirus infection. Our findings have greatly facilitated 
the understanding of the mechanisms underlying  parvovirus DNA replication, and have 
provided a molecular basis for the novel strategy by which DNA viruses subvert the host cellular 
DDR signaling to make it conducive for viral DNA replication. Our study also sheds light on the 
identification of efficient anti-viral targets for the treatment of parvovirus-caused diseases. 
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Chapter 1 
Introduction 
 
Parvovirus infection-induced DNA damage response 
 
Introduction 
Parvoviruses are among the smallest DNA viruses and are widely spread in humans and 
many other species [1,2]. Parvovirus is non-enveloped with an icosahedral virion of 18-26 nm in 
diameter. It contains a linear single-stranded (ss)DNA genome of 5-6 kb, which is flanked by two 
terminal hairpin repeats. The Parvoviridae family is composed of two subfamilies: Parvovirinae, 
which infects vertebrates, and Densovirinae, which infects only invertebrates. The subfamily 
Parvovirinae contains five genera: Amdovirus, Bocavirus, Dependovirus, Erythrovirus and 
Parvovirus [3]. Adeno-associated viruses (AAVs), in the genus Dependovirus, replicate only 
during coinfection with other helper viruses, such as adenovirus or herpes virus [4]. All other 
parvoviruses replicate autonomously in their respective host cells and therefore are called 
autonomous parvoviruses [5,6]. 
Parvoviruses enter host cells through receptor-mediated endocytosis, and  traffic into 
the nucleus, where viruses are uncoated and viral genomes are released. Released viral 
genomes are amplified by host cellular replication machinery; meanwhile, viral genomes are 
transcripted into viral mRNAs, which are spliced and exported into the cytoplasm. In the 
cytoplasm, viral mRNAs are translated into capsid proteins and non-structural proteins. Capsid 
proteins together with mature viral genomes are assembled in the nucleus and finally released 
from host cells through the lysis of both nuclear and cytoplasmic membrane. [2] (Figure 1) 
 
2 
 
 
 
 
 
     
 
 
 
3 
 
As intracellular parasites, parvoviruses modulate the host cellular environment through 
the control of the cell cycle as well as the regulation of cell signaling pathways. Due to their 
simplistic gene expression profiles [3,7], parvoviruses largely rely on host cellular factors for 
productive infections. In order to propagate their DNA genomes, most parvoviruses arrest host 
cells at S phase for access to the cellular DNA replication machinery [8–14]; however, 
observations of G2/M arrest of host cells are also widely reported, especially during the late 
infection [14–18]. Moreover, parvovirus infections also induce cytopathic effects, which are 
characterized by their abilities to induce apoptosis, necrosis and autophagy [19–26]. The cell 
cycle arrest and cell death induced by parvovirus infections have been reviewed previously [27]. 
Although both in vitro and in vivo studies have suggested that basic cellular DNA replication 
factors are required for parvoviral DNA replication, accumulating evidence has suggested that 
the cellular DNA damage response (DDR) plays an important role in parvovirus replication 
[28–30]. 
DDR was originally identified as a cellular safeguarding system that protects cellular 
genome integrity and stability [31,32]. Mammalian cells are constantly challenged by many kinds 
of stresses that include intrinsic sources such as reactive oxygen species (ROS) produced from 
regular metabolisms, and extrinsic sources such as ultraviolet (UV), ionizing irradiation, and 
chemical treatment. These inducers create several types of damaged DNA structures, including 
single-stranded DNA breaks (SSBs), double-stranded DNA breaks (DSBs) and stalled 
replication forks [33,34]. The DDR signaling is a complex signal transduction pathway that is 
transduced by three components: sensors, mediators and effectors. The central mediators in the 
pathway are three phosphatidylinositol 3-kinase-like kinases (PI3KKs): ATM (ataxia 
telangiectasia-mutated kinase), ATR (ATM- and Rad3-related kinase), and DNA-PKcs 
(DNA-dependent protein kinase catalytic subunit) [34,35]. In response to different damaged DNA 
structures, different sets of DDR sensors are recruited. DSBs can be recognized by the 
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Mre11-Rad50-NBS1 (MRN) complex, which further activates the ATM kinase [36]. The ATM 
kinase has hundreds of substrates, which are effectors involved in cell cycle checkpoint, DNA 
repair and apoptosis [37–40]. DSBs can also be bound by the Ku70 and Ku80 complex, which 
recruits DNA-PKcs, a critical player in DNA repair of non-homologous end joining [41]. The ATR 
signaling pathway is in response to SSBs, stalled replication forks and DSBs resection. In SSBs 
and stalled replication forks, the ssDNA regions are coated with replication protein A (RPA), 
which loads Rad17 and the Rad9-Rad1-Hus1 (9-1-1) complex, to recruit TopBP1 (DNA 
topoisomerase 2-binding protein 1) [42–45]. TopBP1 further sequesters ATR, which is 
transformed into a hyperphosphorylated status by autophosphorylation at multiple sites [46]. 
Meanwhile during DSBs resection, single-stranded overhangs are formed, which promote an 
ATM-to-ATR switch [46,47]. Following the binding of sensors and activation of these three 
PI3KKs, a number of downstream effectors, including DNA repair proteins and cell cycle 
checkpoint proteins, are recruited and phosphorylated. Depending on the extent of DNA 
damage, cells are arrested at different phases of the cell cycle either for repairing the damage or 
triggering apoptosis if the damage is beyond repairing [33]. 
Interactions between DNA viruses and the host DDR machinery have been widely 
documented [48–51]. In contrast to triggering the protection effect of the DDR, viruses have 
evolved sophisticated strategies to redirect the DNA damage machinery. By selectively 
activating or suppressing components of the DDR, viruses are able to modulate the cellular 
environment for viral infections. Several reviews have summarized the relationship of different 
DNA virus species, especially double-stranded (ds)DNA viruses, to the DDR machinery [48–51]. 
The interaction between viruses and the DNA damage machinery not only significantly affects 
the viral life cycle but also play important roles in viral pathogenesis. Among the smallest DNA 
viruses, parvoviruses must exploit cellular machineries and signaling pathways, including DDR 
signaling pathways, for a productive viral infection. In addition, since parvoviruses contain 
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ssDNA genomes with unique hairpin structures at the ends (Figure 2), which are absent from 
cellular DNA, they are unique tools to study exogenous DNA-induced DDR. This review aims to 
summarize recent advance in parvovirus infection-induced DDR, with an emphasis on the 
diversity of signaling pathways utilized by different parvoviruses and the impact of the DDR 
machinery on the parvovirus life cycle as well as host cell fate decisions. 
 
Genus Dependovirus (Adeno-associated virus type 2, AAV2) 
 Replication of AAV2 requires co-infection of a helper virus, such as adenovirus and 
herpes virus, via modulating the host cellular environment and activating viral gene expression 
[52]. In the absence of helper virus, the AAV2 genome can integrate into a specific locus on 
human chromosome 19 as latent infection [53]. AAV2 has not been associated with any human 
diseases and presents very low immunogenicity. Thus, it has been modified as one of the 
promising vectors in human gene therapy [54,55]. The AAV2 genome has identical inverted 
terminal repeats (ITRs), forming “T” shaped hairpins at each end (Figure 2) [56]. Studies about 
AAV2 infection-induced DDR have been performed under different conditions, i.e., infection of 
UV-inactivated AAV, transduction of recombinant AAV2 (rAAV2), coinfection of AAV2 and 
adenovirus, and coinfection of AAV2 and herpes virus type 1 (HSV1).  
The MRN complex is a barrier to efficient AAV2 replication and rAAV2 transduction [57]. 
Adenovirus was the original identified helper virus for AAV2 productive infection [58]. The 
minimal set of adenovirus proteins required for AAV2 replication includes E1A, E1b55K, E4orf6, 
and VA RNA genes [59]. During adenovirus infection, E1b55K and E4orf6 proteins form a 
complex, which is important for export of viral mRNA [60,61]. The complex also causes the 
degradation of the MRN complex, promoting productive adenovirus infection by preventing the 
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concatemerization of adenovirus genomes [62]. During either AAV2 replication or processing of 
transduced rAAV2, the MRN complex was found to relocalize into the foci with AAV2 genomes 
[57,63]. Mre11 physically associated with rAAV2 genomes [63], and Mre11 and NBS1 bound to 
AAV2 ITR hairpin structures [57]. Thus, the MRN complex has an intrinsic ability to bind to the 
hairpin structures of AAV2 genomes. Notably, the MRN complex is not required for activation of 
the DDR signaling during AAV replication; conversely, it limits AAV2 replication and rAAV2 
transduction efficiency. Silencing of NBS1 increased rAAV2 focus formation and rAAV2 
transduction, while degradation of the MRN complex by E1b55K/E4orf6 created a more 
favorable environment for both wild type AAV2 replication and rAAV2 transduction [57]. 
Therefore, the MRN complex may initially function as an anti-virus cellular apparatus, while 
AAV2 requires the E1b55K/E4orf6 complex encoded from adenovirus to destroy this machinery. 
During coinfection of AAV2 and adenovirus, DNA-PKcs signaling is the major mediator of 
the induced DDR [64,65]. The DDR is represented by phosphorylation of a number of DDR 
factors such as SMC1 (structural maintenance of chromosomes 1), Chk1 (checkpoint protein 1), 
Chk2 (checkpoint protein 2), H2AX, RPA32 [65]. Interestingly, although the MRN complex was 
destroyed during coinfection, autophosphorylation of the ATM kinase was observed [65], even it 
is not the mediator of the DDR. By contrast, DNA-PKcs is the primary mediator of the DDR in 
response to AAV2 and adenovirus coinfection. Along with its regulatory subunits, Ku70 and 
Ku86, DNA-PKcs localized to the AAV2 replication centers as well as the large non-structural 
protein Rep-mediated AAV2 replication compartments that only contain the AAV2 replication 
origins (p5 promoter and the ITR) [65]. In addition, DNA-PKcs plays an important role in AAV2 
DNA replication in vitro as well as rAAV2 replication in the presence of adenovirus or HSV1 [66]. 
DNA-PKcs also has been reported to be involved in the formation of circular rAAV2 episomes 
[67,68]. However, during coinfection with adenovirus, wild type AAV2 DNA replication is not 
dramatically affected by DNA-PKcs inhibition [64]. Although it has not been shown whether the 
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ATR signaling is activated during AAV2 and adenovirus coinfection, expression of a kinase-dead 
ATR did not affect the downstream signaling, indicating that the ATR signaling is not involved 
[65]. Thus, during coinfection of AAV2 and adenovirus, both the ATM and the DNA-PKcs 
signaling pathways are activated, although the DNA-PKcs is the major mediator of the signaling. 
During coinfection with HSV1, AAV2 replication activates the ATM and the DNA-PKcs 
signaling [69]. The helper proteins provided by HSV1 include UL5, UL8, UL52 and the DNA 
binding protein ICP8, which play important roles in HSV1 replication [70]. HSV1 infection alone 
activates the ATM signaling and inhibits ATR signaling [71,72]. Moreover, DNA-PKcs is inhibited 
through ICP0-dependent proteasomal degradation [73]. During coinfection with HSV1, AAV2 
infection induced phosphorylation of all the three PI3KKs, and delayed the degradation of 
DNA-PKcs [69]. DNA-PKcs and ATM phosphorylated several downstream substrates such as 
NBS1, p53, Chk2, H2AX and RPA. Although ATR phosphorylation and recruitment of its binding 
component ATRIP (ATR-interacting protein) were observed, Chk1 was not phosphorylated, 
indicating that the ATR signaling is not activated [69]. However, whether phosphorylation of 
these kinases affects the AAV2 life cycle during the coinfection with HSV1 has not been studied. 
Both the AAV2 genome and the large non-structural proteins Rep78/68 are able to 
induce a DDR. The structure of the AAV2 genome has a gap of ~4.4 kb between the two ITRs 
(Figure 2). This structure could mimic a SSB, and is a perfect trigger for the activation of the ATR 
signaling [42,74]. Indeed, studies on infection of UV-inactivated AAV2 proved that the AAV2 
genome is able to induce a DDR, which arrests host cells at G2/M phase in the presence of p53, 
and apoptosis in the absence of p53 [75]. UV irradiation causes the formation of intra-strand 
cross-links in the AAV2 ssDNA genome, resulting in no expression of viral proteins.   
UV-inactivated AAV2 formed foci in infected cells, and DNA polymerase delta, ATR, TopBP1, 
RPA, and the 9-1-1 complex were found to colocalize within the foci, suggesting that 
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non-replicative AAV2 genome, by mimicking a stalled replication fork, provokes ATR-Chk1 
signaling [76]. Activated Chk1 is required for the G2/M arrest following UV-AAV2 infection 
[77,78]. In addition, ectopic expression of the Rep proteins was able to activate the DDR 
signaling [10,65], possibly due to the endonuclease activity of the Rep proteins which creates 
non-specific nicks in chromosome DNA. However, during coinfection with adenovirus, the DDR 
signaling elicited by the Rep proteins was much weaker than that from AAV2 replication [65], 
suggesting that the majority of DDR signaling is generated from the replication event rather than 
from the Rep proteins or viral genome per se. 
The consequences of DDR activation on virus life cycle and the host cell fate varies from 
different conditions of viral infection. Infection of UV-inactivated AAV2 triggers G2/M arrest of 
host cells and activates p84N5, a proapoptotic protein that further activates caspase-6 and 
induces p53-independent apoptosis in several cancer cell lines [78,79]. Notably, AAV2 can 
replicate autonomously (to a limited extent) in UV-treated host cells [80], suggesting that DDR 
signaling may trigger replication of AAV2 DNA. Additionally, ectopic expression of the large Rep 
proteins induced ATM-dependent S phase arrest that facilitated AAV2 replication [10]. However, 
during coinfection with adenovirus or HSV1, the consequences of DDR on the AAV2 lifecycle 
and host cell fate are still elusive, since these two helper viruses also interact with the cellular 
DNA damage machinery. Interfering with any DDR signaling alters the life cycle of these two 
viruses [81] and therefore indirectly affects AAV2 replication.  
In conclusion, under different conditions of viral infection, AAV2 displays diverse patterns 
to interplay with the cellular DNA damage machinery. The MRN complex is a barrier to wild-type 
AAV2 replication and rAAV2 transduction. Although effects such as cell cycle arrest and 
apoptosis were observed during expression of the large Rep proteins and infection of 
UV-inactivated AAV, little is known about the impact of DDR signaling on the fate of host cells 
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and the life cycle of AAV2 during coinfection with its helper viruses. Nevertheless, study of 
AAV2-induced DDR will help us to better understand the biology of AAVs for enhancing rAAV 
transduction and preventing potential hazards of using AAV vectors in human gene therapy. 
 
Genus Erythrovirus (Human parvovirus B19, B19V) 
B19V belongs to the genus Erythrovirus and naturally only infects human erythroid 
progenitor cells (EPCs) of the human bone marrow and fetal liver [82–86]. Most commonly, B19V 
infection causes a mild disease called “fifth disease” [87]. In some conditions, B19V infection 
leads to more severe symptoms, e.g., in pregnant women during the second trimester, B19V 
infection induces hydrops fetalis [88]; in immunocompromised patients, it causes chronic pure 
red cell aplasia [89–91]; and in sickle cell disease patients, it induces transient aplastic crisis 
[92,93]. 
The B19V genome contains two symmetric ITRs (Figure 2). Under a single p6 promoter, 
it encodes three non-structural proteins (NS1, 11-kDa and 7.5-kDa) and two capsid proteins 
(VP1, VP2). The large non-structural protein NS1 is a multiple-functional protein with 
endonuclease, helicase, and transactivation activities [94]. NS1 per se is able to trigger G2/M 
arrest and apoptosis [18,95]. The 11-kDa protein has been shown to induce apoptosis [96], while 
the function of the 7.5-kDa remains unknown. Ex vivo-expanded EPCs are highly permissive to 
B19V infection [97], which was greatly increased under hypoxic conditions [98,99]. In contrast to 
other autonomous parvoviruses, whose infection induces S phase arrest during early infection 
[8–14], B19V infection induces G2/M arrest of infected UT-7/Epo-S1 cells [15] and EPCs 
[18,100,101] , a stage at which the arrested cells have a 4N DNA content as determined by DAPI 
(4′,6′-diamidino-2-phenylindole hydrochloride) staining. However, a more careful examination of 
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B19V-infected EPCs using a proliferation assay of BrdU-incorporation combined with DAPI 
staining [102,103] showed that B19V-infected EPCs were actually arrested at late S phase, 
which have a 4N DNA content (Y. Luo & J. Qiu, unpublished). This observation suggests 
replication of B19V, like other autonomous parvoviruses, requires cellular replication factors 
expressed in S phase. 
B19V infection triggered a broad range of DDR, resulting in all three PI3KKs activated in 
infected EPCs, which localized to the B19V DNA replication centers [28]. Downstream effectors 
of the these kinases, such as Chk1, Chk2 and Ku70/Ku86 proteins, also colocalized within the 
replication centers, indicating that B19V has a powerful ability to activate the DNA damage 
machinery. This phenomenon is somehow similar to that observed during AAV2 and HSV1 
coinfection [69]. The difference is that ATR phosphorylates Chk1 during B19V infection, whereas 
phosphorylated ATR did not contribute to Chk1 activation during AAV2 and HSV1 coinfection.   
Replication of the B19V genome is required for triggering a DDR [101]. Expression of 
individual viral protein, including NS1, 11-kDa, 7.5-kDa, VP1 and VP2, in EPCs failed to induce a 
DDR [101]. Although studies in B19V-nonpermissive cells, e.g., the hepatocyte cell line HepG2, 
showed that B19V NS1 was able to nick cellular chromosome DNA and caused damage of 
cellular DNA [104], DDR in response to such potential DNA damage was not obvious during 
ectopic expression of the NS1 in EPCs as neither H2AX nor RPA32 was phosphorylated [101]. 
In UT7/Epo S1 cells, which are permissive to B19V infection [15], transfection of a B19V 
infectious DNA, but not a replication-deficient mutant that harbors mutation in the NS1 
endonuclease motif, activated a DDR, indicating that the DDR induced by B19V is closely 
associated with the status of viral DNA replication [101]. The requirement of the viral replication 
process to trigger a robust DDR is similar to what was observed during AAV2 and adenovirus 
coinfection [65]. However, whether B19V ssDNA genome per se can induce a DDR warrants 
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further investigation. The ATR-Chk1 signaling facilitates B19V DNA replication [28]. Either 
inhibition of ATR activation by the treatment of an ATM/ATR-specific pharmacological inhibitor or 
transient knockdown of ATR significantly blocked B19V DNA replication. During B19V infection, 
Chk1 was phosphorylated and localized into the viral DNA replication centers. Inactivation of 
Chk1 phosphorylation by the treatment of a Chk1-specific pharmacological inhibitor also reduced 
B19V replication. Additionally, the DNA-PKcs signaling contributes to enhance B19V DNA 
replication but to a lesser extent. Interestingly, although the ATM signaling and its substrate 
Chk2 were activated during B19V infection, knockdown of ATM and inhibition of Chk2 
phosphorylation did not affect B19V DNA replication significantly. Thus, the function of ATM 
signaling during B19V infection remains unknown. 
Interestingly, B19V infection-induced DDR does not contribute to the G2/M arrest (a 
phase with a 4N DNA content) during infection [28,101]. Although both checkpoint kinases Chk1 
and Chk2 have the ability to induce G2/M arrest [105–107], inhibition of either Chk1 or Chk2 
activation in EPCs did not abolish G2/M arrest induced during B19V infection [28]. Additionally, 
knockdown of p53, which is phosphorylated at serine 15 by ATM, failed to abrogate B19V 
infection-induced G2/M arrest [101]. These results suggest that a p53- and 
Chk1/Chk2-indendeptnt pathway is involved in G2/M arrest induced during B19V infection. 
Indeed, the NS1 protein per se is able to induce G2/M arrest through deregulation of E2F family 
proteins [100]. A mutant infectious clone with a mutating putative transactivation domain of NS1 
[101] replicated well in UT7/Epo S1 cells and induced a DDR, but not obvious G2/M arrest [101]. 
Thus, B19V infection-induced DDR is dispensable for the G2/M arrest induced during infection. 
In conclusion, B19V infection not only triggers a broad range of DDR activation, but also 
hijacks ATR and DNA-PKcs for viral DNA replication. Viral DNA replication but not individual viral 
protein is required for B19V infection-induced DDR. The DDR has an unclear effect on the host 
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cellular environment since it is dispensable for the G2/M arrest of infected cells; however, it 
facilitates B19V DNA replication. It will be interesting to know whether the downstream effectors 
of ATR and DNA-PKcs signaling are involved in DDR-promoted B19V replication. Further study 
is warranted to examine the difference in the G2/M or late S (4N) phase arrest induced between 
by B19V infection and by the NS1 protein using the BrdU-incorporation/DAPI staining 
proliferation assay. Such an examination will reveal the role of the DDR in the cell cycle arrest 
during B19V infection. 
 
Genus Parvovirus (Minute virus of mice, MVM; Parvovirus H-1, H1-PV)  
-MVM 
MVM has been used as a classic model to study the replication mechanism of 
autonomous parvoviruses [108,109]. Together with H1-PV, they are oncolytic parvoviruses due 
to their ability to selectively infect and kill various human tumor cells and inhibit tumorigenesis in 
animal models [110]. In contrast to AAV2 and B19V, the terminal hairpins of the MVM and H1-PV 
genomes are asymmetric (Figure 2). During MVM infection, MVM replicates in the viral 
replication centers, so called the autonomous parvovirus-associated replication (APAR) bodies, 
which include NS1, NS2 and several cellular DNA replication factors, i.e., polymerase delta, 
polymerase alpha, RPA and PCNA (proliferating cell nuclear antigen) [111]. Replication of MVM 
requires host cells at S phase, which was reported to be induced by NS1 protein [17]. 
MVM infection induces a DDR that is predominantly regulated by ATM signaling [29,112]. 
In both MVM-infected murine and human cells, DDR factors, e.g., H2AX, Nbs1, Chk2 and p53, 
were phosphorylated [29]. RPA32 is hyper-phosphorylated at multiple sites, including serines 4, 
8 and 33; however, the function of the phosphorylation remains unknown [112]. Although many 
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of these phosphorylated proteins relocate into the APAR bodies, proteins such as γH2AX and 
phosphorylated MDC1 appeared to be diffused in some of the infected cells [112]. With treatment 
of an ATM-specific inhibitor, the majority of the phosphorylation events were reduced, indicating 
that ATM signaling is the major mediator of MVM infection-induced DDR [29]. By contrast, ATR 
signaling seems to be deregulated during MVM infection of asynchronous A9 cells, although it is 
not clear whether this is true in other cell lines [112]. In MVM-infected NB324K cells, DNA-PK 
components, Ku70 and Ku86, localized to the APAR bodies [29]. However, whether DNA-PKcs 
is phosphorylated during MVM infection was not examined. 
Viral DNA replication is required for an MVM-induced DDR [29]. Ectopic expression of 
NS1, NS2 or NS1 plus NS2 did not generate significant levels of DDR signaling [29]. Infection of 
wild-type MVM and NS2-knockout mutant induced a similar DDR in asynchronous A9 cells, 
further suggesting that NS2 is not required for DDR induction [112]. Expression of NS1 induced a 
slightly increase in the level of γH2AX, which is likely due to the non-specific nicking function of 
NS1 [29,113]. The finding that UV-inactivated MVM at low MOI (multiplicity of infection) failed to 
induce an obvious DDR indicates that neither viral proteins nor viral genome alone is able to 
induce a DDR comparable to that observed during MVM replication [29].  
ATM signaling contributes to MVM DNA replication [29]. Treatment of MVM-infected cells 
with an ATM-specific inhibitor significantly blocked MVM DNA replication [29]. However, Mre11, 
the sensor for ATM activation, was degraded during MVM infection [29]. DNA-PKcs signaling 
contributes minimally to MVM replication [29]. Whether the ATR signaling affects MVM DNA 
replication and host cell cycle arrest has not been studied. Inhibition of ATM signaling 
ameliorated MVM infection-induced G2/M arrest, indicating that ATM signaling partially 
contributes to MVM infection-induced cell cycle arrest [29]. Since Chk2 is phosphorylated during 
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MVM infection [29], it is likely that Chk2 plays a role in MVM infection-induced G2/M arrest during 
late infection. 
Taken together, MVM infection mainly hijacks ATM signaling for viral DNA replication. We 
speculate that ATM- or Mre11-deficient cell lines do not support MVM replication. ATM signaling 
also partially contributes to MVM infection-induced G2/M arrest. The viral DNA replication event 
is required for the induction of DDR. It is not clear how ATM signaling promotes viral DNA 
replication. Since MVM replication is limited in cells at S phase [11,12,114], it is unknown yet 
whether ATM signaling regulates S phase arrest during early infection.   
-H-1PV 
H-1PV infection triggers a DDR that is mediated by reactive oxygen species (ROS) 
production [23]. ROS are chemically generated in cells treated with xenobiotic agents such as 
peroxides and oxidants, or by-products of the oxygen metabolism. Accumulation of such 
molecules causes oxidative stress, which damages cellular structures through initiation of 
apoptosis [115]. Recent studies also show that ROS production is a general source of DDR 
activation [116]. 
In contrast to the MVM NS1 protein, H-1PV NS1 per se induces apoptosis, ROS 
production and a DDR [23]. Either H-1PV infection or only NS1 expression in NS1-inducible 
stable cell line caused G2/M arrest and cytotoxic effects. NS1 expression-induced apoptosis was 
mediated through the activation of caspase-3 and -9. NS1 expression alone induced a high level 
of γH2AX, suggesting that the H-1PV NS1 protein has an intrinsic ability to induce a DDR. H-1PV 
infection increased ROS production. Treatment of H-1PV-infected or NS1-expressing cells with 
antioxidants blocked ROS production and decreased γH2AX expression, indicating that the 
NS1-induced ROS production contributes to DDR activation. In concert, antioxidant treatment 
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blocked the NS1-induced apoptosis. These results demonstrated that H1-PV NS1 has the ability 
to cause oxidative stress through upregulation of ROS production, which is likely due to cellular 
DNA damage, such as DSBs, induced by the NS1 non-specific nicking of chromosome DNA. 
Collectively, H-1PV NS1 protein induces a DDR through regulating ROS production, 
which is responsible for the apoptosis induced during infection. It is unknown yet which DDR 
pathway is activated during H-1PV infection or by NS1 expression alone. More importantly, 
whether the DDR signaling plays a role in the H-1PV replication remains to be answered. 
 
Genus Bocavirus (Minute virus of canines, MVC) 
MVC belongs to the genus Bocavirus, which also includes bovine parvovirus 1 (BPV1) 
and the newly identified human bocavirus HBoV [117–119]. MVC contains two asymmetric 
terminal hairpins (Figure 2) [118]. Walter Reed/3873D (WRD) cells were widely used for MVC 
infection [120]. MVC infection of WRD cells triggered a gradual cell cycle change from S phase 
arrest in early infection to G2/M arrest in late infection as well as mitochondrion-mediated 
apoptosis [121]. MVC infection activates the ATM signaling [30]. In contrast to MVM infection, 
ATR was phosphorylated during MVC infection. γH2AX was distributed in a pannuclear pattern, 
while phosphorylated RPA32 colocalized within the MVC replication centers. Inhibition of ATM 
signaling blocked H2AX phosphorylation, while inhibition of both ATM and ATR signaling by 
pan-inhibitors blocked RPA32 phosphorylation, indicating that both ATM and ATR signaling 
pathways are activated. Whether DNA-PKcs is phosphorylated has not been confirmed, due to 
the lack of a suitable antibody. However, neither knockdown of DNA-PKcs nor treatment of 
MVC-infected cells with a DNA-PKcs-specific inhibitor affected phosphorylation of H2AX and 
RPA32, strongly suggesting that DNA-PKcs signaling is not activated during MVC infection. The 
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MRN complex colocalized with MVC NS1 at the early stage of infection, while at the late stage, 
the Mre11 protein appeared to be degraded. 
MVC DNA replication is required for MVC infection-induced DDR [30]. Individual 
transfection of an infectious clone and its derivatives generated positive DDR signaling as long 
as the derivative plasmid is able to replicate [30], which is similar to that in MVM- or 
B19V-induced DDR [29,104]. We speculate that MVC proteins may not cause a significant 
damage to cellular DNA, and that DDR signaling may come mainly from viral DNA replication 
events, i.e., specific nicking of viral DNA by the MVC NS1 protein or production of the viral DNA 
intermediates that are aberrant from any cellular DNA structure. 
MVC hijacks ATM signaling for viral DNA replication [30]. Progeny virus production was 
reduced when the ATM signaling was inactivated. Neither knockdown of ATR nor DNA-PK had a 
negative effect on MVC DNA replication. Ablation of Mre11 by its specific siRNA reduced MVC 
DNA replication, suggesting that the MRN complex functions as a mediator to activate ATM 
signaling in the early stage of MVC infection. 
ATM signaling affects two aspects of host cells during MVC infection. On one hand, 
similar to MVM, inhibition of ATM signaling ameliorated but not diminished the G2/M arrest [30]; 
On the other hand, ATM phosphorylated p53 at serine 15, which contributed to MVC 
infection-induced cell death. Knockdown of p53 did not affect MVC infection-induced G2/M arrest 
but rescued about 50% of cells from cell death in the late stage of infection [30]. Since p53 is a 
well-established linker between DDR and apoptosis [39,122,123], and MVC infection does 
trigger a mitochondrion-mediated apoptosis [121], it was proposed that phosphorylation of p53 
by the ATM signaling during MVC infection directly contributes to MVC infection-induced 
apoptosis, through which progeny virus can be quickly released from lysed host cells for another 
round of infection [30]. 
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In summary, MVC hijacks ATM signaling to facilitate viral DNA replication and thereafter 
progeny virus production. Similar to MVM and B19V, MVC DNA replication is necessary for DDR 
induction. Activation of ATM signaling partially contributes to MVC infection-induced G2/M arrest, 
although it is not clear whether this is because of the direct activation of the G2/M checkpoint or a 
delay of S phase progression. Indeed, we observed that MVC infection trigged an intra-S phase 
arrest that is dependent upon the ATM signaling pathway (Y. Luo & J. Qiu, unpublished 
observation). The intra-S phase arrest not only blocked cellular DNA replication, but also delayed 
S phase progression. Therefore, we speculate that in the context of the intra-S phase arrest, 
MVC represses cellular DNA replication and continuously hijacks the cellular DNA replication 
machinery. These findings revealed the beneficial effects of the ATM activation on autonomous 
parvovirus DNA replication, and suggest a novel model for parvovirus DNA replication. 
  
Conclusion 
Parvoviruses have evolved sophisticated strategies to coexist with their host species. 
Although their genomes are aberrant from any cellular DNA structure, and the proteins 
expressed from the viral genome are limited, they are able to propagate in various host cells of 
different species. Studies about DDR induced during parvovirus infection have uncovered novel 
mechanisms underlying virus-host interactions. For Dependovirus AAV2, DDR proteins, such as 
the MRN complex, function as a barrier for viral infection, and this barrier can be destroyed by 
the helper virus. By contrast, in autonomous parvoviruses, the DDR machinery is hijacked by 
viruses in order to create a cellular microenvironment conducive for viral DNA replication. 
Therefore, parvoviruses are able to utilize different strategies to adapt to their host cells and 
modulate the host cellular environment. The DDR induced by different parvoviruses is 
summarized in Figure 2.  
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Both viral proteins and the ssDNA genome of parvoviruses are able to elicit a DDR. The 
nonstructural protein of parvoviruses, i.e., the NS1 protein of H1-PV and MVM, and the large 
Rep proteins of AAV2, are able to induce a DDR without the presence of viral genomes 
[10,23,29,65,113], indicating that they may create damaged cellular DNA though their 
endonuclease functions. The UV-inactivated AAV2 genome triggered ATR-Chk1 signaling 
[78,79]. However, during infection of MVM, MVC, B19V and coinfection of AAV2 and adenovirus, 
the DDR signaling is majorly activated from the DNA replication events [28–30,65], likely due to 
the specific nicking of viral DNA or generation of viral DNA intermediates that mimic damaged 
DNA. 
  During infection of autonomous parvoviruses, the DDR machinery is hijacked to 
facilitate viral DNA replication [28–30]. However, the MRN complex is a barrier to AAV2 
replication and rAAV transduction when adenovirus is coinfected or its helper genes are 
expressed [57]. It is still unknown whether the three DDR pathways have an impact on the life 
cycle of AAV2 during coinfection, because both adenovirus and HSV1 interfere with the DDR 
machinery as well. The DDR machinery regulates cell cycle arrest and apoptosis induced during 
parvovirus infection. DDR triggered either by expression of the largest nonstructural viral proteins 
of parvoviruses [10,17,23,113] or by infection of autonomous parvoviruses [28–30] is able to 
arrest infected cells at S phase or G2/M phase. UV-inactivated AAV2-induced DDR not only 
arrests cells at G2/M [78], but also triggered apoptosis in tumor cells [79]. Viral infection-induced 
apoptosis was also observed following DDR activation during MVC infection, which activates the 
ATM-p53 signaling pathway [30]. Hence, parvovirus infection-induced DDR influences the host 
cell fate through cell cycle regulation and apoptosis induction. The mechanisms by which viral 
infection-induced DDR coordinates host cell cycle change and apoptosis require further 
investigation. 
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Objectives 
Studies on parvovirus-induced DDR have greatly facilitated the understanding of 
parvovirus replication. Since using AAV2 as a model to study the relationship between the DDR 
and parvovirus DNA replication is very complicated due to the presence of the helper viruses, we 
aim to understand the basic mechanisms underlying autonomous parvovirus infection induced 
DDR by using MVC and B19V as model organisms.  
In this study, in the first place, we aim to confirm that whether the DDR activation is a 
general feature of autonomous parvovirus infection. Next, we try to examine the detailed 
signaling pathways of DDR in each infection conditions of these two viruses. We also want to 
know the consequences of the DDR on infected host cells as well as viral life cycle.   
     Since autonomous parvovirus replicates in cells at S phase and induces a DDR, we also 
speculate that DDR-induced cell cycle arrest at either intra-S phase or late S phase (with a 4N 
DNA content) plays a critical role in DDR-promoted parvovirus DNA replication. The mechanisms 
by which parvoviruses induce S phase arrest by the DNA damage machinery and how DDR 
signaling facilitates viral DNA replication are also topics in this study. 
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Chapter 2 
Bocavirus Infection Induces a DNA Damage Response That Facilitates 
Viral DNA Replication and Mediates Cell Death   
 
Abstract 
Minute virus of canines (MVC) is an autonomous parvovirus that replicates efficiently 
without helper viruses in Walter Reed/3873D (WRD) canine cells. We previously showed that 
MVC infection induces mitochondrion-mediated apoptosis and G2/M-phase arrest in infected 
WRD cells. However, the mechanism responsible for these effects has not been established. 
Here, we report that MVC infection triggers a DNA damage response in infected cells, as evident 
from phosphorylation of H2AX and RPA32. We discovered that both the ATM 
(ataxia-telangiectasia mutated) and ATR (ATM and Rad3-related) kinases were phosphorylated 
in MVC-infected WRD cells, and confirmed that ATM activation was responsible for the 
phosphorylation of H2AX, whereas ATR activation was required for the phosphorylation of 
RPA32. Both pharmacological inhibition of ATM activation and knockdown of ATM in 
MVC-infected cells led to a significant reduction in cell death, a moderate correction of cell cycle 
arrest, and, most importantly, a reduction in MVC DNA replication and progeny virus production. 
Parallel experiments with an ATR-targeted siRNA had no effect. Moreover, we identified that this 
ATM-mediated cell death is p53-dependent. In addition, we localized the Mre11-Rad50-Nbs1 
(MRN) complex-the major mediator as well as a substrate of the ATM-mediated DNA damage 
response pathway to MVC replication centers during infection, and show that Mre11 knockdown 
led to a reduction in MVC DNA replication. Our findings are the first time to support the notion 
that an autonomous parvovirus is able to hijack the host DNA damage machinery for its own 
replication and for the induction of cell death.  
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Introduction 
Bocavirus is a newly classified genus of the family Parvovirinae, and includes human 
bocavirus (HBoV), minute virus of canines (MVC) and bovine parvovirus (BPV). HBoV was 
recently associated with acute respiratory wheezing and pneumonia [124–126], and is commonly 
detected in association with other respiratory viruses [125,126]. In addition to being linked to 
respiratory illnesses, HBoV has been associated with gastroenteritic diseases [127–131]. Within 
their respective hosts, two closely related animal bocaviruses share these characteristics 
[132–137]. Although differentiated human airway epithelial cells were recently shown to support 
HBoV replication, the fact that this was at an extremely low level [138] makes this system a 
difficult one to study HBoV biology. MVC infection of Walter Reed/387D (WRD) cells, however, 
has been proven much more efficient [118,120]. Using this system, we have shown that MVC 
infection induces mitochondrion-mediated apoptosis, that this effect is dependent on replication of 
the viral genome, and that the MVC genome per se is able to arrest the cell cycle at the 
G2/M-phase [121].   
Infection by many DNA viruses has been found to induce a cellular DNA damage 
response (DDR), which can either block or enhance viral DNA replication, as well as cell cycle 
arrest (in response to mild damage) or apoptosis (in response to irreparable damage), in infected 
cells [49]. DNA damage rapidly activates conserved DDR pathways [139,140] that involve three 
PI-3-kinase-like kinases (PI3Ks): ATM (ataxia telangiectasia mutated), ATR (ATM and Rad3 
related), and DNA-PK (DNA-dependent protein kinase) [106,141,142]. ATM is primarily activated 
as a result of DNA double-strand breaks (DSBs), and is recruited to DSBs by the 
Mre11-Rad50-Nbs1 (MRN) complex. ATR, on the other hand, responds to the detection of 
single-stranded DNA (ssDNA) breaks and stalled DNA replication forks, and is recruited to 
RPA-coated ssDNA by an ATR-interacting protein (ATRIP) [140,143]. Like ATM, DNA-PK is 
activated in response to DSBs, but it is recruited to the damage site in complex with Ku70 and 
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Ku80. Once recruited to a site of damage, ATM, ATR and DNA-PK phosphorylate a number of 
substrates (including H2AX, RPA, CHK1 and CHK2, p53, SMC1, Nbs1 and BRCA1) that in turn 
target other proteins, with ultimate outcome being the silencing of CDKs and an arrest of 
cell-cycle progression to promote DNA repair or elimination of the potential hazardous cells by 
apoptosis [140,144,145]. 
 Parvovirus contains a linear ssDNA genome with terminal repeat structures at both ends 
[146]. Adeno-associated virus 2 (AAV2), a member in the genus Dependovirus of the family 
Parvovirinae, in the case of infection by (UV-inactivated) AAV2 alone, provokes a DDR that 
mimics stalled replication forks, with both ATM and ATR being activated, resulting in the 
phosphorylation of CHK1 and H2AX and G2-phase arrest [75,76,147]. It is the p5 promoter 
sequence, rather than the AAV2 terminal repeats, that triggers DDR [147]. However, when AAV2 
undergoes a productive infection in the presence of adenovirus, AAV2 DNA replication activates 
a DDR that is primarily mediated through DNA-PK pathway, and leads to phosphorylation of the 
downstream targets H2AX, RPA32, Nbs1, CHK1, CHK2 and SMC1 [64,65] in the absence of the 
MRN complex [65]. Replication of AAV2 requires degradation of the MRN complex, an upstream 
regulator essential for activation of the ATM pathway [57].  For this, AAV2 requires the help of 
another virus, such as adenovirus. Adenovirus per se can induce DDR and cell death [148]. 
Therefore, a simple model for studying the relationships among parvovirus DNA replication, DDR 
and induced cell death has not been established. 
In the current study, we provide the first evidence that infection by MVC, an autonomous 
parvovirus, triggers a DDR that is represented by phosphorylation of both H2AX and RPA32. We 
show that both ATM- and ATR-mediated pathways are involved in the MVC infection-induced 
DDR, but that only the ATM-mediated pathway, which is sensed by the MRN complex, is critical 
for replication of the MVC genome and MVC-infection-induced cell death.   
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Materials and Methods 
Cell and virus:  
 WRD canine cells were maintained in Dulbecco’s modified Eagle’s medium with 10% 
fetal calf serum in 5% CO2 at 37°C. The MVC strain used in this study is the original strain GA3, 
which was isolated at the College of Veterinary Science, Cornell University. MVC was cultured 
and quantified as previously described, and the virus titer was determined as the number of 
fluorescence-focus forming units (ffu) per ml [121]. The WRD cell line and MVC strain were 
obtained as gifts from Dr. Colin Parrish at Cornell University. WRD cells were infected with MVC 
at a multiplicity of infection (MOI) of 5.  
  
Chemicals and treatment:  
Hydroxyurea (HU, Calbiochem) was diluted to deionized water as a stock solution at 250 
mM. Inhibitors, CGK733, KU55933, NU7441 and Wortmannin, were bought from Calbiochem, 
and were diluted in DMSO as stock solutions at 10 mM. BrdU was purchased from Sigma and 
diluted in deionized water as a stock solution at 5 mM. 
WRD cells were seeded on 60-mm dishes one day prior to chemical treatment. KU55933, 
CGK733, NU7441 and Wortmannin were applied to cells at a final concentration of 20 μM, 2.5 
μM, and 10 μM, respectively, 3 hrs prior to infection. 0.25% DMSO was used as a DMSO control. 
HU was added to cells at a final concentration of 2.5 mM in parallel with MVC infection. 
  
siRNA, plasmid and transfection: 
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siRNA oligos were synthesized as dicer-substrate RNAi at Integrated DNA technologies 
(IDT, Coralville, Iowa). The following siRNA sequences were chosen for targeting the genes of 
interest: siRNA specific to ATM (siATM): 5’-GUACUAGUUGCUUGUGUAACUGUA-3’; siRNA 
specific to ATR (siATR): 5’-AGAAAGGAUUGUAGGCUAAUGGAA-3’; siRNA specific to 
DNA-PK catalytic subunit (siDNA-PKcs): 5’-CUAGGAAAUCCAUCGGUAUCAUUAA-3’; siRNA 
specific to Mre11 (siMre11): 5’-GGUCUUCUACUCUUAGGGUUGUUCCUU-3’; siRNA specific 
to p53 (sip53): 5’- CCACCAUCCCUAAACUAAUGTG-3’. The following scrambled RNA 
(Scrambled) was used as a siRNA control: 5’CUUCCUCUCUUUCUCUCCCUUGUGA3’. 
Transfection of all the siRNAs was performed using Trifectin reagent (IDT) following the 
manufacturer’s instructions. At 48 hrs post-transfection, the cells were fed with fresh medium 
and infected with MVC. 
MVC plasmids, pIMVC, pIMVCNS1(-), pIMVCNP1(-),  pIMVCVP1/2(-), and 
pMVCNSCap, and the method for transfection have been described previously [118,121]. 
  
Antibodies:   
Anti-MVC NS1 and anti-MVC NP1 antisera were produced previously [118,121]. 
Anti-γH2AX (Millipore Corporate), anti-phospho(p)-RAP32(Ser33) (Bethyl Laboratories, Inc.), 
anti-phospho(p)-ATM (Ser1981) (Rockland Immunochemicals Inc.), anti-Rad50 (GeneTex Inc.),  
anti-p-SMC1(Ser957) (Genscript USA Inc.), and anti-ATM, anti-ATR and anti-DNA-PKcs 
(Calbiochem,  EMD Chemicals Inc.) were used in this study. Both a monoclonal anti-Mre11 
antibody (clone 12D7, GeneTex), which was generated by immunizing a truncated Mre11 from 
aa182 to 582, and a polyclonal anti-Mre11 antibody (C-16, Santa Cruz Biotechnology Inc.), 
which was raised against a peptide mapping near the C-terminus of human Mre11, were used to 
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detect Mre11. Anti-p-ATR(Ser428), anti-p-Nbs1(Ser343), and anti-p-p53(Ser15) were obtained 
from Cell Signaling Inc. Antibody dilutions used for Western blotting and immunofluorescence 
analysis were as suggested in the manufacturers’ instructions.   
  
Western blotting and immunofluorescence:  
Western blotting and immunofluorescence assays were performed as previously 
described [121]. Confocal images were taken at a magnification of 100 × (objective lens), with an 
Eclipse C1 Plus confocal microscope (Nikon) controlled by Nikon EZ-C1 software.   
For BrdU incorporation, WRD cells were seeded on a chamber slide and infected with 
MVC at an MOI of 5. At 18 hrs p.i., BrdU was added into the cell culture medium at a final 
concentration of 5 μM. At 24 hrs p.i., cells were fixed and co-immunostained with rat anti-MVC 
NS1 and mouse anti-BrdU to mark the MVC replication centers. 
 
Southern blotting analysis: 
Low-molecular-weight DNA (Hirt DNA) was extracted from WRD cells, and DpnI digestion 
and Southern blotting were performed as described previously using the MVC NSCap probe as 
described previously [118]. 
 
Virus titration assay: 
WRD cells were transfected with siRNAs for 48 hrs, or treated with inhibitors for 3 hours 
prior to MVC infection (MOI = 5). At 48 hrs p.i., both the cells and medium were collected and 
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lysed by repeated freezing and thawing. After lysis, the samples were briefly centrifuged and the 
supernatants were collected for the virus titration assay. 
WRD cells were seeded on 4 well-chamber slides (Lab-Tek, USA) 24 hrs prior to 
infection. Virus samples were serially diluted in ten-fold and added to each well. At 24 hrs p.i., 
cells were fixed in 100% acetone and stained with anti-MVC NS1 and then processed for 
immunofluorescence assay. The number of fluorescence-positive cells in each chamber was 
counted. This number of focus-forming units in each well was calculated by multiplying the 
number of fluorescence-positive cells per chamber by the dilution of the virus-containing 
supernatant. The viral titer is expressed as the average number of focus-forming units per ml of 
supernatant (ffu/ml). 
  
Flow cytometry analysis: 
Live/Dead Violet staining for detection of cell death and DAPI staining for analysis of cell 
cycle were performed as described previously [121]. All of the processed samples were analyzed 
on a three-laser flow cytometer (LSR II; BD Biosciences) at the Flow Cytometry Core of the 
University of Kansas Medical Center. All flow cytometry data were analyzed using FACS DIVA 
software (BD Biosciences). 
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Results 
 MVC infection causes a DNA damage response (DDR) in infected cells. 
To examine whether DDR is induced during MVC infection, we evaluated the 
phosphorylation status of H2AX and RPA32 in MVC-infected cells. First, we used BrdU 
incorporation to identify the MVC DNA replication centers, and inspected whether anti-BrdU 
staining colocalizes with the MVC NS1 protein. As shown in Fig. 1A, NS1 was present at active 
replication foci, as indicated by anti-BrdU staining. In subsequent experiments, we used anti-NS1 
staining as a marker for the MVC DNA replication centers.  
MVC-infected cells were co-immunostained with anti-NS1 and anti-phosphorylated H2AX 
(γH2AX) or with anti-NS1 and anti-RPA32 phosphorylated at serine 33 (p-RPA32). In parallel, we 
treated cells with hydroxyurea (HU), an agent known to induce DDR [149,150], as a positive 
control. At 48 hrs postinfection (p.i.), we found that MVC infection led to significant increases in 
the levels of both γH2AX and p-RPA32 in NS1-expressing cells (Fig. 1B&C, MVC-infected), with 
most of the NS1-expressing cells (red) also positive for anti-γH2AX or anti-p-RPA (green), 
respectively. Interestingly, p-RPA32 colocalized with NS1 at replication foci, but γH2AX did not 
(Fig. 1B&C, MVC-infected). In the HU-treated positive control cells, γH2AX and p-RPA32 were 
also expressed in the nuclei (Fig. 1B&C, HU-treated). Thus MVC infection specifically induces 
the phosphorylation of H2AX and RPA32. Western blot analysis revealed that H2AX and RPA32 
were increasingly phosphorylated over time (Fig. 1D). Both H2AX and RPA32 were 
phosphorylated starting at 18 hrs p.i., and were maximally phosphorylated at 36 hrs p.i.; this 
correlated with the level of MVC replication as assessed NS1 expression (Fig. 1D). Collectively, 
these findings show that MVC infection induces a significant DDR that is correlated with MVC 
replication.    
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Figure 1. MVC infection induces a DDR.   
 (A) Detection of the MVC DNA replication foci using BrdU incorporation. Punctuate 
staining by anti-NS1 (red) or anti-BrdU (green) antibody indicates the replication foci. (B&C) 
Immunofluorescence analysis of MVC infection-induced DDR. At 48 hrs p.i., MVC-infected cells 
were co-immunostained with anti-MVC NS1 (red) and anti-γH2AX (green) (B) or anti-MVC NS1 
(red) and anti-p-RPA(Ser33) (green) (C). Cells treated with hydroxyurea (HU) were used as a 
positive control for an induced DDR [149,150]. Nuclei were marked by DAPI staining. (D) 
Western blotting analysis of MVC infection-induced DDR. MVC-infected cells were harvested at 
the indicated time points and analyzed by Western blotting. In addition to the levels of the MVC 
NS1 protein, phosphorylation of the DDR markers H2AX and RPA32 was assessed using 
appropriate antibodies. The same membrane was reprobed with each antibody. HU-treated cells 
served a positive control, and anti-β-actin was used as a loading control. Arrow shows 
phosphorylated RPA32 at serine 33, two bands of phosphorylated RPA32 were detected in 
HU-treated cells.   
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Both ATM and ATR are activated in the MVC infection-induced DDR.    
We examined which kinase pathway underlies the DDR induced during MVC infection. 
First, we used pharmacological inhibitors to ATM, ATR and DNA-PK to block the phosphorylation 
of these kinases. Both the ATM-specific inhibitor KU55933 [151] and the ATR/ATM-specific 
inhibitor CGK733 [152–157] reduced γH2AX levels by approximately 5-fold compared with those 
in untreated control cells (Fig. 2A, lanes 3&4 vs. 2); this did not hold true for the DNA-PK inhibitor 
NU7441 [158] (Fig. 2A, lane 5). CGK733 also significantly interfered with the phosphorylation of 
RPA32, whereas KU55933 and NU7441 did not (Fig. 2B). The pan-PI3K inhibitor Wortmannin 
[159] also inhibited the phosphorylation of RPA32, but not as potently as did CGK733 (Fig. 2B). 
Dephosphorylation of ATM by the inhibitors KU55933 and CGK733 was confirmed by 
anti-p-ATM staining (Fig. 2C, lanes 3&4), and ATR dephosphorylation by the inhibitor CGK733 
was confirmed by anti-p-ATR staining (Fig. 2D, lane 4).  
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Figure 2. Treatment with pharmacological inhibitors of ATM and ATR reduces MVC 
infection-induced phosphorylation of H2AX and RPA32, respectively. 
 WRD cells were treated with DMSO (at 0.25%) and inhibitors, and then infected with 
MVC at 3 hrs post-treatment. MVC-infected cells were harvested at 48 hrs p.i. and were lysed for 
immunoblotting using anti-γH2AX (A), anti-p-RPA(Ser33) (B), anti-p-ATM(Ser1981) (C), and 
anti-p-ATR(Ser428) (D). In all blots, anti-β-actin was used to control for loading. Mock-infected 
and HU-treated cells were used as a negative and a positive control, respectively.     
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 We next used siRNA molecules to specifically knock down ATM, ATR and the DNA-PK 
catalytic subunit (DNA-PKcs). As shown in Fig. 3A, the ATM-specific siRNA inhibited ATM 
expression by approximately 4-fold compared with the scrambled siRNA control (Fig. 3A). 
Consistent with an inhibition of ATM expression, the ATM siRNA reduced γH2AX by more than 
5-fold to the background level (Fig. 3D, lane 3), but did not affect phosphorylation of RPA32 (Fig. 
3E, lane 3). Similarly, the ATR-specific siRNA reduced ATR expression (Fig. 3B), and 
accordingly decreased the level of phosphorylated RPA32 to the background level in the mock 
control but not that of γH2AX (Fig. 3D&E, lane 4 vs. lane 1). However, neither phosphorylation 
event was diminished in MVC-infected cells treated with the DNA PKcs-specific siRNA (Fig. 
3D&E, lane 5), in spite of the fact that the DNA-PKcs-specific siRNA inhibited nearly 90% of the 
DNA-PKcs (Fig. 3C, lane 3).   
Together, these results show that the increase in γH2AX during MVC infection is 
mediated by ATM phosphorylation, whereas the increase in RPA32 phosphorylation is a 
consequence of ATR activation. Thus, MVC infection-induced DDR appears to involve activation 
of both the ATM and ATR pathways. Due to the lack of an antibody to detect phosphorylated 
canine DNA-PK, we were not able to test whether DNA-PK is phosphorylated during MVC 
infection. However, based on results using the DNA-PKcs-specific siRNA, we believe that 
DNA-PK is less likely to be involved in DDR induced by MVC infection.   
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Figure 3. Treatment with siRNAs targeting ATM and ATR reduces MVC infection-induced 
phosphorylation of H2AX and RPA32, respectively. 
WRD cells were transfected with the indicated siRNA to silence ATM, ATR or DNA-PK.   
The cells were infected with MVC at 48 hrs post-transfection. (A-C) To confirm the efficiency of 
knockdown, at 48 hrs p.i., cells were collected and lysed for immunoblotting using antibodies 
against ATM (A), ATR (B), and DNA-PKcs (C), respectively. A scrambled siRNA served as a 
negative control. (D&E) To assess the effect of the knockdown on the DDR, at 48 hrs p.i., cells 
were collected and lysed for immunoblotting using anti-γH2AX (D) and p-RPA(Ser33) (E), 
respectively. Both blots were reprobed with anti-β-actin antibody. Mock-infected cells were used 
as a background control.  
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The ATM-mediated DDR plays an important role in inducing the cytopathic effects that 
occur during MVC infection. 
 We used the above-described pharmacological inhibitors and siRNAs to examine the 
effects of inhibiting ATM, ATR and DNA-PK on the cell death that is triggered in WRD cells by 
MVC infection [121]. At 24 hrs and 48 hrs p.i., the cells were harvested for flow cytometry 
analysis with the cell death marker dye Live/Dead Violet and an anti-MVC NS1 antibody. 
NS1-expressing cells were selectively gated to determine the percentage of dead cells. We 
found that when either an ATM inhibitor (KU55933 or CGK733) or an ATM-specific siRNA was 
applied to MVC-infected cells, cell death at 48 hrs p.i. was significantly inhibited (Fig. 4). More 
specifically, treatment with KU55933 and CGK733 reduced cell death by 55% and 84%, 
respectively, over that seen in the DMSO control, and application of the ATM-specific siRNA 
reduced cell death by 70% compared to that achieved when the scrambled siRNA control was 
applied. Treatment of the cells with the ATR-specific siRNA resulted in only a slight inhibition of 
cell death, by approximately 11% (Fig. 4). In contrast, application of neither the DNA-PK inhibitor 
NU7441 nor DNA-PKcs-specific siRNA resulted in significant inhibition of the cell death induced 
by MVC infection at 48 hrs p.i. (Fig. 4). These results suggest that ATM activation is important to 
the cell death induced by MVC infection, whereas the ATR pathway contributes minimally. At 24 
hrs p.i., cells in the DMSO control group did not undergo cell death at a significant level; 
therefore, inhibitory effects of the ATM inhibitor or of the siRNA could not be easily evaluated 
(Fig. 4). Moreover, application of the ATM-specific siRNA inhibited phosphorylation of p53 at 
serine 15 (Fig. 5A). Knocking down the p53 by a p53-speciifc siRNA reduced cell death by 
approximately 61%, compared to the treatment with the scrambled siRNA (Fig. 5B&C), but did 
not correct the cell cycle arrest (Fig. 5D). Thus our results suggest that MVC infection induces an 
ATM-mediated and p53-dependent cell death.  
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Figure 4. Both inhibiting ATM phosphorylation and knocking down ATM expression 
significantly reduce MVC infection-induced cell death.  
WRD cells were treated with inhibitors for 3 hrs prior to MVC infection or transfected with 
the indicated siRNAs 48 hrs prior to MVC infection. (A)  At 24 or 48 hrs p.i., cells were collected 
and analyzed using Live/Dead Violet and anti-NS1 co-staining by flow cytometry. The result 
shown is a representative one from three independent experiments. Percentages of dead cells in 
NS1-expressing cells are shown in each histogram. (B) Statistical analysis of the percentages of 
dead cells in NS1-expressing cells from three independent experiments. Average (numbers) and 
standard deviation (“T”-shaped bars) are shown for each treatment group.  
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Figure 5. MVC infection-induced cell death is dependent on phosphorylation of p53.  
WRD cells were transfected with the indicated siRNAs 48 hrs prior to MVC infection. (A) 
At 48 hrs p.i., cells were collected and lysed for immunoblotting using antibodies against 
phosphorylated p53 at serine 15. The blot was reprobed with anti-β-actin. (B&C) Cells were 
collected and analyzed using Live/Dead Violet and anti-NS1 co-staining by flow cytometry. A 
representative experiment is shown with percentages of dead cells in NS1-expressing cells in 
each histogram (B), and average (numbers) and standard deviation (“T”-shaped bars) are shown 
for each treatment group (C). (D) Cells were collected and analyzed for cell cycle using DAPI and 
anti-NS1 co-staining by flow cytometry. A representative experiment is shown with percentages 
of cells in each cell cycle. 
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We reported previously that a G2/M cell cycle arrest occurs during late MVC infection 
[121]. When KU55933 and CGK733 were applied to WRD cells prior to infection, the G2/M arrest 
that normally occurs at 48 hrs p.i., was inhibited to some extent; only approximately 56% 
(CGK733) and 67% (KU55933) were in the G2/M-phase compared to 76% in the DMSO control 
sample (Fig. 6). In contrast, the DNA-PK inhibitor had not effect (Fig. 6). Consistent with these 
results, only the ATM siRNA reduced the MVC infection-induced G2/M arrest, by approximately 
16%, compared to that seen in the cells treated with the control scrambled siRNA (Fig. 6); neither 
the ATR- nor the DNA-PKcs-specific siRNA had an effect (Fig. 6). These results suggest that 
ATM activation is likely involved in the G2/M cell cycle arrest during MVC infection.   
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Figure 6. Both inhibiting ATM phosphorylation and knocking down ATM attenuate MVC 
infection-induced G2/M arrest. 
(A) WRD cells were treated with inhibitors for 3 hrs prior to MVC infection or transfected 
with siRNAs 48 hrs prior to MVC infection. At 48 hrs p.i., the cells were subjected to flow 
cytometry for an assessment of G2/M arrest using DAPI and anti-NS1 co-staining. The 
percentage of cells in each phase of the cell cycle was quantified and is shown at the bottom. 
Significant changes in the numbers of cells in the G2/M-phase are shown. Mock-infected cells 
were analyzed as a normal cell cycle control. (B). Statistical analysis of the percentage of cells in 
the G2/M-phase in NS1-expressing cells from three independent experiments. Average 
(numbers) and stand deviation (“T”-shaped bars) are shown for each treatment group.  
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The ATM-mediated DDR is required for replication of the MVC genome.  
  To test whether MVC replication was impaired by deactivation of any of the three DDR 
pathways, we evaluated the percentage of MVC infected cells by intracellular staining using 
anti-NS1 antiserum. A typical experiment was shown in Fig. 7A, where at 48 hrs p.i., 
approximately 70% of WRD cells were infected with MVC (Fig. 7A, DMSO and Scrambled). In 
cells treated with KU55933 or CGK733, NS1-expressing cells were decreased to 41.6% and 
11.6%, respectively, of the numbers seen in the control, indicating that ATM inactivation reduced 
MVC infection. Furthermore, knocking down ATM using an ATM-specific siRNA led to a 72% 
decrease in NS1-expressing cells compared to the number in the scrambled siRNA control group 
(Fig. 7A). However, treatment with either an ATR- or a DNA-PKcs-specific siRNAs failed to 
reduce the number of NS1-expressing cells significantly (Fig. 7A). These results indicate that 
ATM activation may facilitate MVC replication.  
 To confirm the role of ATM activation in MVC DNA replication, we treated WRD cells with 
our panel of kinase inhibitors and siRNAs and then analyzed MVC DNA replication by Southern 
blotting analysis. As shown in Fig. 7B, treatment of cells with either KU55933 or CGK733 
reduced the level of the replicative form (RF DNA) of the MVC DNA by approximately 5-fold (Fig. 
7B, lanes 2&3 vs. 5), whereas treatment with the DNA-PK inhibitor NU7441 did not (Fig. 7B, lane 
4). Notably, both KU55933 and CGK733 inhibitors significantly blocked synthesis of the MVC 
ssDNA, by approximately 10-fold (Fig. 7B, lanes 2&3 vs. 5); this effect of ATM inhibition was 
more pronounced when the ATM-specific siRNA was applied (Fig. 7B, lane 8 vs. 7). In contrast, 
ATR- and DNA-PKcs-specific siRNAs failed to inhibit synthesis of both the RF DNA and ssDNA 
of MVC (Fig. 7B, lanes 9&10). The inhibition of ssDNA synthesis was confirmed by measuring 
progeny virus production from MVC-infected cells subjected to each treatment. As expected, the 
virus titers in the ATM-inhibited groups (KU55933-, CGK733- and siATM-treated) were reduced 
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more than 12-fold compared with those in their respective control groups (Fig. 7D, DMSO and 
Scrambled). Consistent with results from Southern blotting analysis, CGK733 treatment reduced 
progeny virus production by 32-fold; however, the inhibition of ATR alone using an ATR-specific 
siRNA did not significantly decrease the production of progeny virus (Fig. 7D, siATR). Likewise, 
treatments of cells with a DNA-PK-specific inhibitor or siRNA, however, did not affect the 
production of progeny virus compared to that seen in the respective controls (Fig. 7D, 
NU7441&siDNA-PKcs).    
Taken together, these results show that the ATM-mediated DDR is essential to MVC 
DNA replication, and that this particular DDR is the most important with respect to synthesis of 
the MVC ssDNA genome during infection. This is the first time to demonstrate that an 
autonomous parvovirus is able to hijack the cellular DNA damage response machinery for its 
productive replication.  
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Figure 7. The ATM pathway is required for MVC DNA replication and progeny virus 
production.  
WRD cells were treated with inhibitors as indicated 3 hrs prior to MVC infection or 
transfected with the indicated siRNAs 48 hrs prior to MVC infection. Mock-infected cells were 
analyzed as a negative control. (A) At 48 hrs p.i., the cells were assessed for MVC NS1 
expression by flow cytometry. The percentage of NS1-expressing cells is shown in each 
histogram. (B) At 48 hrs p.i., one half of the cells were collected for extracting Hirt DNA, and the 
other half were collected and immunoblotted with anti-β-actin. Hirt DNA was normalized based 
on the level of β-actin in each sample, and subjected to analysis by Southern blotting. (C) 
Relative levels of the replicative form (RF DNA) and single-stranded (ssDNA) MVC DNA in each 
group were quantified using Image Quant TL software (GE Health). UD: undetectable. (D) At 48 
hrs p.i., progeny virus was isolated and quantified as ffu/ml as described in Materials and 
Methods. The averages (numbers) and standard deviations (“T”-shaped bars) are shown. 
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The MRN complex facilitates MVC DNA replication.  
To examine whether the MRN complex is involved in MVC DNA replication, we first 
evaluated whether this complex forms in early infection. At 24 hrs p.i., Mre11 in infected cells 
colocalized with the replication foci (punctuate patterns) as well as with Rad50 and 
phosphorylated Nbs1 (p-Nbs1) (Fig. 8A, 24 hrs); in uninfected cells, the Mre11, Rad50 and 
p-Nbs1 were broadly distributed throughout the nuclei without forming bright foci (data not 
shown). As MVC infection proceeded, Mre11 was degraded, as evident from a decrease in 
Mre11 in the MVC replication foci at 48 hrs p.i. (Fig. 8A, 48 hrs). Importantly, Rad50 and p-NBS1 
remained at the same level in these locations as at 48 hrs p.i. (Fig. 8A, 48 hrs p.i.). 
Immunoblotting revealed a clear transition of Mre11 expression between 24 hrs and 36 hrs p.i.  
(Fig. 8B, Mre11); this period corresponds to the time point that is critical for replication of the 
MVC DNA (Fig. 8B, NS1). Notably, starting at 18 hrs p.i., we observed a smaller band of 
approximately 70 kDa (Fig. 8B, Mre11a). This small Mre11 band reached a maximal level at 24 
hrs p.i., and decreased in late infection; this correlates with the timing of MVC DNA replication, 
as indicated by anti-NS1 staining (Fig. 8B, NS1). It was not expressed in HU-treated cells (Fig. 
8B), and was confirmed not to be a viral protein (data not shown). We speculate that it is an 
active form of Mre11, which may play the important role of sensing DSBs and recruiting p-Nbs1 
and Rad50 to the MVC replication foci. We used another anti-Mre11 antibody to confirm that 
Mre11 is degraded. Indeed, a slight reduction of the Mre11 band was observed, and only in 
infected cells, at 24 hrs and 36 hrs p.i. (Fig. 8B, Mre11b). In contrast, the level of Rad50 
remained constant throughout MVC infection (Fig. 8B, Rad50).      
To further explore the role of Mre11 in MVC DNA replication, we knocked down Mre11   
and then measured MVC DNA replication. Unlike the loss of MRN complex function which occurs 
during AAV2 replication when it is co-infected with adenovirus [57], Mre11 knockdown  led to a 
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significant decrease, approximately 3-fold, in MVC DNA replication (Fig. 8C&D). We speculated 
that this was caused by the failure to activate ATM, since the MRN complex acts an upstream 
regulator of the ATM pathway [36,160,161]. Indeed, we found that silencing of Mre11 reduced 
ATM phosphorylation significantly, to a level similar to that produced by ATM knockdown (Fig. 
8E). Moreover, phosphorylation of the ATM substrate SMC1 [162–164] was reduced in this 
context (Fig. 8E). In addition, we found that in contrast to the results we obtained by silencing 
Mre11, knocking down ATM only reduced Nbs1 phosphorylation slightly, indicating that a low 
level of activated ATM is sufficient to phosphorylate Nbs1. As Nbs1 is essential for DSB repair 
and genome stability [165], the persistent presence of p-Nbs1 in the MVC replication foci (Fig. 
8A) suggests that this activated form may play a role in replication of the MVC genome.    
The results here show that the MRN complex localizes to the MVC replication foci, 
indicating that MVC genomes are sensed as DNA damage, likely as DSBs, by the MRN complex 
at the replication foci. On the other hand, colocalization of p-Nbs1 and Rad50 in the MRN 
complex within the MVC DNA replication foci may facilitate replication of the MVC genome. 
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Figure 8. The MRN complex is an upstream regulator of the ATM pathway and facilitates 
replication of the MVC genome. 
(A) Immunofluorescence analysis of colocalization of the MRN complex in MVC 
replication center. At 24 or 48 hrs p.i. as indicated, Mre11, phosphorylated Nbs1 at serine 343 
(p-Nbs1), and Rad50 were examined for co-localizing with MVC NS1 using their respective 
antibodies. A monoclonal anti-Mre11 antibody (clone 12D7) was used to detect Mre11. (B) 
Western blot analysis of MVC-infected cells. MVC-infected cells were collected at various times 
p.i. as indicated, and were analyzed by immunoblotting for the level of Mre11. Mre11 was 
examined using anti-Mre11 monoclonal antibody (Mre11a, upper panel) vs. a polyclonal antibody 
(Mre11b, middle panel). The blot was reprobed using anti-Rad50 (Rad50), and anti-NS1 (NS1), 
and anti-β-actin (β-actin) antibodies, sequentially. (C&D) WRD cells were transfected with the 
Mre11-speciifc siRNA (siMre11) and a scrambled siRNA as a control 48 hrs prior to MVC infection. 
Mock-infected cells were used as a negative control. At 48 hrs p.i., cells were collected and 
immunoblotted with anti-Mre11 and reprobed using anti-β-actin (C); Hirt DNA was prepared from 
infected cells, normalized based on the level of β-actin in each sample, and analyzed by Southern 
blotting. (E) WRD cells were transfected with siRNAs as indicated 48 hrs prior to MVC infection. 
At 48 hrs p.i., the cells were collected and immunoblotted with anti-Mre11(C-16, Santa Cruz) and 
reprobed sequentially with anti-p-ATM(Ser1918), anti-p-SMC1(Ser957), anti-p-Nbs1(Ser343), 
and β-actin. Mock-infected cells were used as a background control. 
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Replication of the MVC genome induces the DDR. 
 We next sought to explore which viral components are involved in MVC infection-induced 
DDR. We transfected the MVC infectious clone, pIMVC, as well as its derivatives pIMVCNS1(-), 
pIMVCNP1(-),  pIMVCVP1/2(-), and the NSCap-expressing construct pMVCNSCap, in which 
both terminal repeats were deleted, into WRD cells, separately (Fig. 9C). At 48 hrs p.i., we 
analyzed transfected cells for anti-γH2AX staining, and co-stained all samples except 
pIMVCNS1(-)-transfected cells with anti-NS1; pIMVCNS1(-)-transfected cells were co-stained 
with anti-NP1. Transfection of pIMVC induced phosphorylation of H2AX in ~80% of 
NS1-expressing cells at 48 hrs p.i. (Fig. 9A). H2AX was not phosphorylated in NP1-expressing 
cells and in NS1-expressing cells transfected with the replication-defective constructs 
pIMVCNS1(-) and pMVCNSCap, respectively [118,121] (Fig. 9A). Transfection of the NP1 
knock-out construct, pIMVCNP1(-), which replicates poorly [118], also failed to induce significant 
phosphorylation of H2AX, whereas transfection of the pIMVCVP1/2(-) induced phosphorylation 
of H2AX in ~40% of NS1-expressing cells (Fig. 9A). Consistent with this result, transfection of the 
replicative constructs pIMVC and pIMVCVP1/2(-) phosphorylated p53 in ~10% and 5% in 
NS1-expressing cells, respectively, but transfection of the non-replicative MVC constructs did not 
(Fig. 9B), suggesting that activation of the death signaling cascade requires a high level of DDR. 
In the context of knockout of both VP1 and VP2, in pIMVCVP1/2(-)-transfected cells, the MVC 
genome was replicated at a level approximately 2 times less than that measured in 
pIMVC-transfected cells (Fig. 9C).  
  These results indicate that expression of the MVC protein(s) [NS1 in 
pIMVCNP1(-)-transfected cells, NP1 in pIMVCNS1(-)-transfected cells, or NS1, NP1 and VP1/2 
in pMVCNSCap-transfected cells] is not sufficient to induce H2AX or p53 phosphorylation. 
Instead, H2AX and p53 phosphorylation is tightly associated with replication status of the MVC 
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genome. These results suggest that at least replication of the MVC genome is required to induce 
a DDR (Fig. 9D). 
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Figure 9. Replication of the MVC genome is required to trigger a DNA damage response.  
WRD cells were transfected with pIMVC, its mutants pIMVCNP1(-),pIMVCNS1(-) and 
pIMVCVP1/2(-),  and an MVC NSCap-expressing construct, indicated on left. Untransfected 
cells were set up as the control. (A&B) At 48 hrs p.i., cells were fixed and co-immunostained with 
anti-γH2AX, anti-NS1/NP1, and DAPI (A), or anti-p-p53(ser15), anti-NS1/NP1, and DAPI (B). (C) 
Hirt DNA was isolated from transfected cells, digested with DpnI and analyzed by Southern 
blotting. Arrowhead indicates a faint DpnI-resistant band [121]. (D) Transfected plasmids are 
illustrated, and results concluded from panels A-C are shown. Asterisk denotes a very low level 
of replication. LTR, left hand terminal repeat; RTR, right hand terminal repeat.      
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Discussion 
In this study, we have demonstrated that MVC infection leads to phosphorylation of H2AX 
and RPA32, hallmarks of DDR [150,166–170], and that both the ATM- and ATR-mediated 
pathways are activated. In some respects, the DDR induced by MVC infection is beneficial to 
virus infection, i. e., facilitating replication of viral DNA, especially, synthesis of ssDNA, as well as 
inducing cell death, which is essential for virus egress. On the other hand, MVC 
infection-induced DDR is detrimental to the host in that it leads to activation of cell-cycle 
checkpoints and apoptosis of infected cells. Notably, the DDR was not triggered by expression of 
viral proteins and the delivery of plasmids containing the non-replicative MVC DNA, but rather by 
replication of the MVC DNA. Thus, we provide convincing evidence that a DDR induced by 
autonomous parvovirus plays critical roles in the virus life cycle and virus infection-induced 
cytopathic effects.   
 
MVC infection induced a DDR mediated by both ATM and ATR pathways.  
ATR and its downstream effector RPA32 were phosphorylated during MVC infection, and 
phosphorylated RPA32 colocalized with MVC NS1 in the replication centers (Fig. 1B). 
Interestingly, RPA32 is an ssDNA binding protein that is essential for replication of both the 
minute virus of mice (MVM) [171] and AAV2 [172] genomes. Activation of ATR and subsequent 
phosphorylation of RPA32 have been shown to play a pivotal role in the DDR induced by 
infection with UV-inactivated AAV2 [76,147]. Moreover, AAV2 DNA replication activates 
DNA-PK, which then phosphorylates RPA32 at multiple sites [65]. RPA32 phosphorylation also 
has been shown to increase as infection by EBV progresses [173]. However, in our study, we 
found that inhibition of RPA32 phosphorylation by silencing ATR did not affect MVC DNA 
replication. In fact, it has been reported that RPA32 phosphorylation appears to occur outside the 
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cellular replication sites [174]. CGK733 inhibits both ATM and ATR activation [152–157], and 
was the most effective inhibitor of DDR-mediated cell death and cell cycle arrest in MVC-infected 
cells. We believe that these potent inhibitory effects are due to the fact that CGK733 is a more 
potent inhibitor of ATM than is the ATM-specific inhibitor KU55933 in WRD cells, rather than due 
to its additional inhibition of ATR phosphorylation.   
The DDR that is induced during SV40 infection has been suggested to be activated by 
the large T antigen via Bub1 binding [175]. The large T antigen also interacts with the MRN 
complex [176–178]. The HPV E7 protein directly binds to ATM, and this induces an 
ATM-mediated DDR upon HPV infection of differentiated epithelia [179]. In parvoviruses, both 
AAV2 Rep78 and parvovirus H-1 NS1 have been implicated in the phosphorylation of H2AX 
[10,23], which was hypothesized to occur as a response by either non-specific nicking of the 
cellular DNA by Rep78 [10], or NS1-induced reactive oxygen species (ROS) as a DNA damage 
agent [23]. However, Rep78 only accounts for a small portion of the DDR that is induced during 
AAV2 replication [65]. Notably, our results suggest that neither NS1 nor a stalled replication fork 
(Fig. 9), which would be potentially assembled in the region of the MVC replication origin to 
activate ATR [76,147], is responsible for DDR induced during MVC infection. The low level of 
DNA replication achieved by transfection of the NP1-deficient infectious clone [pIMVCNP1(-)] in 
WRD cells failed to induce a clear DDR. Given that a moderate level of genome replication is 
absolutely required for MVC-induced DDR, we hypothesize that specific nicking of the replicative 
form (RF) of the MVC genome by the helicase activity of NS1 may create lesions that mimics 
DSBs (Fig. 10, c), and that DDR is triggered when this signal accumulates to a certain level. In 
fact, ATM is a prime candidate for mediating the cellular damage response to DSBs [161], as 
DSBs are sensed by the MRN complex that triggers ATM-mediated H2AX phosphorylation 
[161,180]. How ATM is activated during virus infection is not clearly understood. Based on 
studies of HSV-1, it was proposed that DSBs may arise as a consequence of replication fork 
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collapse at sites of oxidative damage [181,182], possibly due to cleavage of the viral α 
sequences by endonuclease G during genome isomerization [183,184]. Parvovirus NS1 nicks 
only the positive strand of the RF DNA at the terminal resolution site [185], and it has been 
shown that opening of the DNA helix is required for MRN stimulation of functional ATM [36,161]. 
Self-complementary recombinant AAV2 (scAAV), of which the genome is a RF DNA, contains 
palindromic hairpin-structured terminal repeats, which resemble a repair intermediate of DSBs. 
Thus, NS1-nicked RF DNA and unpaired (replication) intermediates (Fig. 10, d&e) might be 
perfectly opened DNA helices that function as DSBs and trigger ATM activation. 
In addition, delivery of the AAV2 genome by UV-inactivated AAV2 has been proven to 
induce ATM/ATR-mediated DDR [75,76,147], which differs from the DNA-PK-mediated DDR 
induced by AAV2 DNA replication [64,65]. In our study, we observed that the extent of DDR 
induced by MVC DNA replication somehow correlated with the replication efficiency and the 
accumulation of the ssDNA genome during infection. Interestingly, H2AX was significantly 
phosphorylated when cells were inoculated with UV-inactivated MVC at a high MOI of 40, but not 
at a low MOI of 5 (data not shown). Thus, we speculate that the accumulated ssDNA genome of 
MVC may also contribute to DDR induced during infection (Fig. 10, g), which warrants further 
investigation.   
Based on the information summarized above, we hypothesize that during the virus life 
cycle, replication of the MVC genome leads to an accumulation of strand breaks, and that these 
are registered as DSBs and thus trigger ATM activation. RPA-coated ssDNA breaks, on the 
other hand, could potentially trigger ATR activation (Fig. 10, a&f) during replication [42]. Notably, 
MVM infection also induced an ATM-activated DDR that helps MVM DNA replication in 
MVM-permissive cells (David Pintel, personal communication). Both MVC and MVM are 
autonomous parvovirus, meaning that replication of their genomes does not require the function 
from a helper virus. Thus, both the MVC and MVM infection systems provide simple models in 
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which to study the DDR induced by the ssDNA genome of parvovirus. It is now clear that, like 
other DNA viruses [49,186], the autonomous parvovirus hijacks the cellular DDR machinery to 
facilitate replication of its genome.          
 
Only ATM activation-mediated DDR facilitates MVC DNA replication and elicits cell death 
in MVC-infected cells.          
Although MVC infection induces activation of both ATM and ATR, we found that only the 
ATM-mediated DDR contributes to MVC DNA replication and cell death. In response to DNA 
damage, cells activate a complex network of factors [144,145] that silence CDKs and thereby 
arrest the cell cycle, promoting DNA repair [187]. Interestingly, MVC-infection impaired cell 
proliferation and disturbed the cell cycle, allowing a transition from the S-phase accumulation to 
the G2/M arrest as the infection progresses [121]. Thus, MVC infection-induced DDR supports 
replication of the viral DNA by first arresting cell-cycle progression at the S-phase, and then 
impairing the cell cycle at the G2/M-phase to prevent mitosis, which would lead to apoptotic cell 
death. On the other hand, if the cell sustains DNA damage that cannot be repaired, the DDR 
triggers a cascade of apoptotic cell death, through either a p53-dependent or p53-independent 
pathway [122]. We found that p53 was phosphorylated upon MVC infection and that is 
dephosphorylated in the context of ATM inactivation (Fig. 5). Furthermore, replication of 
transfected MVC RF DNA induced phosphorylation of p53 albeit in a low level (Fig. 9), which 
presumably is due the low level of DNA replication by transfection compared with that during 
MVC infection. These findings suggest that phosphorylated ATM activates apoptosis in a 
p53-dependent manner (Fig. 10). Bax translocalization and caspase activation have been shown 
to occur during cell death triggered by MVC infection [121]. We hypothesize that phosphorylated 
p53 may activate the BH3-only molecules, e.g., tBID, BIM and PUMA, which further activate 
Bax/Bak  [188].       
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We have demonstrated that ATM-mediated DDR is involved in cell cycle arrest to some 
extent, which is p53-independnet. We believe that CHK2 (checkpoint kinase 2) likely signals to 
activate this ATM-mediated G2/M arrest [145]. Notably, we did not observe a clear DDR in cells 
transfected with non-replicative and poorly replicating MVC constructs (Fig. 9). The cell cycle of 
these transfected cells, however, was arrested at G2/M-phase [121]. We think that the DDR 
induced replication of the MVC genome may not fully account for the cell cycle arrest during 
MVC infection, and that an unknown mechanism may contribute to the cell cycle arrest induced 
by the viral genome, specifically the terminal repeats [121]. Actually, both inhibition of ATM 
activation and knockdown of ATM only moderately rescued the cell cycle arrest. It could also be 
that a low level of DDR induced by the MVC genome, which is able to induce cell cycle arrest but 
not cell death [121], is not sufficient to induce a significant increase of γH2AX. Therefore, in the 
context of the DDR induced during MVC infection, it may be easier to prevent cell death than to 
prevent arrest of the cell cycle.       
   
The MRN complex localizes to the MVC replication center. 
MRN complex is involved in the initial processing of DSBs as a sensor, and is required for 
ATM activation by DNA damage [36,160,161,189]. It is also critical to the repair of DNA damage 
[190,191]. The MRN complex is required to signal DDR induction during HSV-1 infection [192], 
mutant adenovirus infection [193] and HPV infection [179]. In contrast, the MRN complex has to 
be destroyed during adenovirus [62], AAV2 [57], and SV40 [194] infections. During MVC 
infection, the MRN complex was assembled at early stages of infection, but Mre11 was slightly 
degraded at later stages, while the virus was actively replicating. A loss of Mre11 at later times 
following HSV-1 infection has also been reported [195]. However, the MRN complex was 
co-localized to the MVC replication center during the course of MVC infection. Further evidence 
that Mre11 knockdown reduced MVC replication by approximately 3-fold (Fig. 8) strongly 
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supports that the notion that the MRN complex is required for replication of the MVC genome 
(Fig. 10), and that its role may be to recruit DNA repair factors to the replication center [175], as 
the p-Nbs1 is essential to DSB repair [165]. On the other hand, the MRN complex senses ATM 
activation, which in turn may mediate proteasome-dependent degradation of the MRN subunit 
[194] at later stages of infection.           
 HSV-1, SV40 and HPV have all been shown to induce ATM-mediated DDR whereby a 
number of repair factors are recruited to the replication center [179,194,196,197]. Exactly, how 
the DDR microenvironment helps viral DNA replication is largely unknown. DSBs can be 
repaired by either of two distinct repair pathways: non-homologous end joining (NHEJ) or 
homologous recombination (HR) [198]. Components of these repair machineries have been 
shown to support viral DNA replication [49]. For example, DDR-induced Rad51 facilitates 
replication of the EBV and SV40 genomes [173,199]. Studying MVC replication-induced DDR 
and how this response feeds back to help MVC DNA replication will likely help us to understand 
the mechanism underlying virus infection-induced DDR.     
 
In conclusion, MVC infection-caused cytopathic effects are unique, and are mediated by 
DDR induced by replication of the viral genome. We believe that the DDR is induced during 
parvovirus infection, and that the ensured cell death and cell cycle arrest maybe common, and 
potentially synergistic mechanisms underlying parvovirus infection-induced cytopathic effects. 
Understanding the mechanism underlying MVC-induced DDR, and the DDR-induced cell death 
and cell cycle arrest pathways will potentially elucidate the molecular pathogenesis of Bocavirus 
infection, as well as unravel the mechanism underlying the regulatory DDR pathways.   
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Figure 10. Proposed DNA damage response pathways induced during MVC infection.  
The proposed pathways are described in detail in Discussion. Model of MVC DNA 
replication refers to DNA replication of the minute virus of mice [185]. Bax translocalization and 
caspase activation have been shown previously [121] to induce apoptotic cell death during MVC 
infection, and upregulation of cyclinB/CDK1 was confirmed to be responsible for the G2/M arrest 
that is induced during MVC infection [121]. L, left hand terminal repeat; R, right hand terminal 
repeat. 
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Chapter 3 
Parvovirus B19 infection of primary human erythroid progenitor cells 
triggers ATR-Chk1 signaling, which promotes B19 replication 
 
 
 
Abstract 
Human parvovirus B19 (B19V) infection is restricted to erythroid progenitor cells of the 
human bone marrow. Although the mechanism by which the B19V genome replicates in these 
cells has not been studied in great detail, accumulating evidence has implicated involvement of 
the cellular DNA damage machinery in this process. Here, we report that, in ex vivo expanded 
human erythroid progenitor cells, B19V infection induces a broad range of DNA damage 
responses by triggering phosphorylation of all the upstream kinases of each three repair 
pathways: ATM (ataxia-telangiectasia-mutated), ATR (ATM and Rad3-related) and DNA-PKcs 
(DNA-dependent protein kinase catalytic subunit). We found that phosphorylated ATM, ATR and 
DNA-PKcs, and also their downstream substrates and components (Chk2, Chk1, Ku70/Ku80 
complex, respectively) localized within the B19V replication center. Notably, inhibition of kinase 
phosphorylation (through treatment with either kinase-specific inhibitors or kinase-specific 
shRNAs) revealed requirements for ATR and DNA-PKcs, but not ATM, signaling, in virus 
replication. Inhibition of the ATR substrate Chk1 led to similar levels of decrease in virus 
replication, indicating that signaling via the ATR-Chk1 pathway is critical to B19V replication. 
Notably, the cell cycle arrest characteristic of B19V infection was not rescued by interference 
with the activity of any of the three repair-pathway kinases. 
 
 
66 
 
Introduction 
Human parvovirus B19 (B19V), a member of the genus Erythrovirus within the family 
Parvoviridae [200], has been associated with a broad spectrum of human diseases. Most 
commonly, it causes a mild rash in children; this form is known as “fifth disease” [201]. However, 
in some circumstances, B19V infection leads to more severe symptoms. Examples of these 
diseases include hydrops fetalis, in pregnant women infected during the second trimester; 
chronic pure red cell aplasia, in immunocompromised patients; transient aplastic crisis, in sickle 
cell disease patients [88,201].  
B19V contains a single-stranded DNA (ssDNA) genome; it is approximately 5.7-kb in 
length and features two identical terminal repeats (ITRs) at both ends [202]. Replication of the 
B19V genome is restricted to nuclei of human erythroid progenitor cells (EPCs) [173,203]. In ex 
vivo expanded EPCs, B19V infection induces apoptosis [21,96] and arrests cell cycle at the 
G2/M transition [100]. Analyses in ex vivo expanded EPCs infected with B19V have revealed that 
the large nonstructural protein NS1, which is multifunctional and essential to B19V DNA 
replication [94], causes the cell cycle arrest [100] and also plays a role in triggering 
infection-associated apoptosis [21,96]. In addition, we have demonstrated that cellular signaling 
pathways triggered by the binding of erythropoietin (Epo) to its receptor (EpoR) are critical to 
B19V infection of ex vivo expanded EPCs [204]. Beyond the fact that NS1 and EpoR signaling 
are involved, however, we know little about the mechanisms by which the B19V genome 
replicates in ex vivo expanded EPCs.  
 Several studies have shown that parvovirus infection induces a DNA damage response 
(DDR) that plays an important role in the replication of parvovirus DNA [29,30,112].  DDR is 
mediated by three PI-3-kinase-like kinases (PI3Ks): ATM (ataxia telangiectasia mutated), ATR 
(ATM and Rad3-related), and DNA-PKcs (DNA-dependent protein kinase catalytic subunit) 
 
67 
 
[32,35]. ATM is activated primarily by double-stranded DNA breaks (DSBs), and is recruited to 
DSBs by the Mre11-Rad50-Nbs1 (MRN) complex [38,205,206]; ATR responds to 
single-stranded DNA breaks (SSBs) and stalled DNA replication forks and is recruited by an 
ATR-interacting protein (ATRIP) to replication factor A (RPA)-coated ssDNA [207]; DNA-PK is 
activated in response to DSBs, and is recruited to damage sites in complex with both Ku70 and 
Ku80 [208]. After any of these kinases is recruited to a site of DNA damage, it phosphorylates a 
number of substrates (e.g., H2AX, RPA32, Chk1, and Chk2), which in turn target other proteins 
to silence cyclin-dependent kinases. This leads to the arrest of cell-cycle progression so that the 
damaged DNA can be repaired, or, in the case of irreparable damage, so that the potentially 
hazardous cells can be eliminated through apoptosis [32,209].   
The kinases that control the DDR can be induced and hijacked by viruses to promote 
replication of the genomes [81]. For example, ATM signaling can be co-opted for this purpose by 
minute virus of canines (MVC) and minute virus of mice (MVM) [29,30,112], and DNA-PK is used 
in the same way by adeno-associated virus 2 (AAV2) during co-infection with adenovirus [64,65]. 
We reasoned that DDR may likewise contribute to the replication of the B19V genome during 
B19V infection of EPCs. The viral titer in the plasma of infected patients can be as high as 1013 
genomic copies per ml [210,211], this overwhelming replication of the B19V genome may well 
lead to a replication stress and elicit a DDR.      
In this report, we describe our investigation of the DDR in ex vivo expanded EPCs 
infected with B19V, in particular with respect to the possibility that DDR plays a role in virus 
replication. We discovered that B19V infection leads to a broad spectrum of DDR events, 
including phosphorylation of all three upstream kinases. We also found that these 
phosphorylated kinases, together with their downstream substrates or components, localize to 
the B19V replication center of the infected cell. In addition, disruption of either the ATR or 
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DNA-PKcs signaling pathway significantly reduces the efficiency of B19V DNA replication 
without disturbing the cell-cycle phenotype of infected EPCs.  
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Materials and Methods 
Cell line and virus:  
Ex vivo expanded CD36+ EPCs were prepared as described previously [97,204]. 
B19V-containing viremic plasma sample P53 was obtained from ViraCor Laboratories (Lee’s 
Summit, MO). The plasma sample was titrated 10-fold and infected CD36+ EPCs. At 24 hrs 
postinfection (p.i.), the cells were fixed and stained with an anti-B19V NS1 antibody [96]. End 
point titers, fluorescence focus-forming units (FFU), were determined at the last dilution that 
gave unequivocal fluorescence. Virus infection was performed at a multiplicity of infection (MOI) 
of approximately 1 (FFU) per cell as described previously [204].   
 
Chemicals and treatments:  
Hydroxyurea (HU, Calbiochem, Darmstadt, Germany) was dissolved in deionized water 
to make a 250 mM stock solution. The pharmacological inhibitors of CGK733, KU55933, 
NU7441, SB218078 (Chk1 inhibitor, abbreviated as Chk1i) and NSC109555 (Chk2 inhibitor, 
abbreviated as Chk2i) were purchased from Tocris Bioscience (St. Louis, MO), and were 
dissolved in DMSO to make a 10 mM stock solution. Caffeine was purchased from Sigma (St. 
Louis, MO) and dissolved in deionized water as a stock solution at 100 mM.  
 Treatment with these pharmacological inhibitors was performed 3 hrs prior to infection 
with virus. KU55933, CGK733, NU7441 and caffeine were applied to cells at final concentrations 
of 10 μM, 2.5 μM, 10 μM and 1 mM, respectively. Chk1i and Chk2i were used at final 
concentrations of 150 nM and 5 μM, respectively. DMSO at 0.25% was used as a non-treatment 
control. EPCs treated with HU at a final concentration of 0.25 mM were used as positive control 
for DDR. 
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Lentiviral vectors and lentivirus transduction: 
   The oligos used to generate shRNAs were synthesized by Integrated DNA 
Technologies (IDT, Coralville, Iowa). shRNA oligos were annealed and ligated to the pLKO-GFP 
vector (Addgene, Inc.), and lentivirus was produced as described previously [204], following the 
manufacturer’s instructions (http://www.addgene.org/plko). The following validated shRNA 
sequences (Sigma, St Louis, MO) were chosen for targeting the genes of interest: shRNA 
specific to ATM (shATM): 
5’-CCGGTGATGGTCTTAAGGAACATCTCTCGAGAGATGTTCCTTAAGACCATCATTTTTG 
-3’; shRNA specific to ATR (shATR): 5’- 
CCGGAAAGAGGCTCCTACCAACGACTCGAGTCGTTGGTAGGAGCCTCTTTCTTTTTG 
-3’; shRNA specific to DNA-PKcs (shDNA-PKcs): 
5’-CCGGCCGGTAAAGATCCTAATTCTACTCGAGTAGAATTAGGATCTTTACCGGTTTTT 
-3’; shRNA specific to Ku70 (shKu70): 
5’-CCGGAAGAGTCTACCCGACATAAGCTCGAGCTTATGTCGGGTAGACTCTTCTTTTTG-3’. 
The following scrambled shRNA (shScrambled) was used as a shRNA control: 
5’CCGGCCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGG GCGACTTAACCTTAGGTTTTTG 
3’. At 48 hrs post-transduction, CD36+ EPCs were infected with B19V. 
  
Western blotting and immunofluorescence:  
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Western blotting and immunofluorescence assays were performed as described 
previously [30]. Confocal images were taken at a magnification of 40 × or 100 × (objective lens), 
with an Eclipse C1 Plus confocal microscope (Nikon) controlled by Nikon EZ-C1 software.   
 
Antibodies used in this study:   
Rat anti-B19V NS1 antibody was produced previously [96]. Other anybodies obtained 
commercially include: anti-γH2AX (Millipore Billerica, MA); anti-Ku70 and 
anti-phospho(p)-RPA32(Thr21) (Epitomics, Burlingame, CA); anti-p-ATM (Ser1981) (Rockland 
Immunochemicals Inc., Gilbertsville, PA); anti-p-DNA-PK(Ser2056) (Genescript, Piscataway, 
NJ); and anti-ATM, anti-ATR, anti-DNA-PK and anti-Ku80 (Calbiochem); anti-p-Chk1(Ser345) 
and anti-p-Chk2(Thr68) were purchased from Cell Signaling Inc. (Danvers, MA). In addition, two 
anti-p-ATR (Ser428) antibodies were obtained from Cell Signaling Inc. for immunofluorescence 
and Santa Cruz (Santa Cruz, CA) for Western blot analysis. Antibody dilutions used for Western 
blotting and immunofluorescence analysis were as suggested in the manufacturers’ instructions.   
 
Southern blot analysis: 
Low-molecular-weight DNA (Hirt DNA) was extracted from CD36+ EPCs as described 
previously [212]. Southern blotting was performed as described previously using the SalI 
digested pM20 probe which contains the full-length B19V genome [212].  
 
Fluorescence in situ hybridization (FISH): 
 
72 
 
 A B19V DNA fragment (nt 802-1295, Genbank accession no.: AY386330) was 
PCR-amplified and subsequently labeled using the Label IT FISH fluorescein Kit (Mirus, Madison, 
WI). In situ hybridization was performed following the manufacturer’s instruction. Briefly, CD36+ 
EPCs were cytospun onto slides, fixed in 1% paraformaldehyde for 30 min, and permeablized 
with 1% triton-100 for 10 min. After permeablization, slides were treated with 5 μg/ml RNase A at 
37oC for 1 hr and washed with 2×SSC (Sodium Chloride-Sodium Citrate) buffer. Slides were 
sequentially dehydrated with 70%, 85% and 100% ethanol in order for 2 min at room 
temperature, and then denatured with 70% formamide for 2 min. Sequentially, slides were 
dehydrated with 70% ethanol (pre-chilled at -20 oC), 85% and 100% ethanol at room temperature 
in order for 2 min each, and hybridized with fluorescein-labeled DNA probe at 37 °C overnight. 
After FISH, slides were treated with antibodies for immunofluorescence analysis. 
 
Flow cytometry analysis: 
We performed flow cytometry analysis as described previously [121]. Briefly, CD36+ 
EPCs were fixed in 1% paraformaldehyde at room temperature for 30 min and permeablized with 
PBS containing 0.5% Tween-20. Cells were sequentially incubated with primary and secondary 
antibodies, and then with DAPI (4',6-diamidino-2-phenylindole) at 1 µg/ml in PBS containing 
0.3% Tween-20. All processed samples were analyzed on a three-laser flow cytometer (LSR II; 
BD Biosciences) at the Flow Cytometry Core at the University of Kansas Medical Center. All flow 
cytometry data were analyzed using FACS DIVA software (BD Biosciences). 
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Results 
B19V infection induces a DNA damage response (DDR) in B19V-infected EPCs. 
To determine whether a DDR is induced during B19V infection of ex vivo expanded 
EPCs, we located the B19V DNA replication center using a FISH-based method with a B19V 
DNA-specific probe. Since the parvovirus large non-structural protein NS1 is essential to 
replication of the viral DNA [12,171,213], we co-stained the FISH-processed B19V-infected 
EPCs with an anti-NS1 antibody [96] to compare their localization. As shown in Fig. 1A, B19V 
NS1 (red) signal overlapped with that for the B19V DNA (green), indicating that the NS1 protein 
was expressed within the viral DNA replication center. In all of the subsequent experiments, we 
used anti-NS1 immunostaining to mark this center. 
           We next examined the expression levels and localization of phosphorylated H2AX 
(γH2AX) and Thr21-phosphorylated RPA32 (p-RPA32), a hallmark of DDR [214–216].  Both 
γH2AX and p-RPA32 were detectable as early as 12 hrs postinfection (p.i.), the time at which 
B19V NS1 first became visible (Fig. 1B&C). γH2AX either formed a ring at the edge of the  
nucleus and completely overlapped with NS1 expression, or was distributed evenly across the 
nucleus and thus had a broader expression domain than NS1 (Fig. 1D). In contrast, p-RPA32 
consistently co-localized with NS1 (Fig. 1D). Overall, damaged foci were detected only in 
NS1-expressing cells. Upregulation of the expression of both γH2AX and p-RPA32 in infected 
cells vs. mock-infected cells was confirmed by Western blotting (Fig. 2B, compare lanes 2 and 
1). Thus, our results demonstrate that B19V infection of EPCs induces a DDR. 
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Figure 1. B19V infection induces a DNA damage response in CD36+ EPCs.   
(A) Combined immunofluorescence- and FISH-based visualization of the B19V 
replication center. Mock- and B19V-infected CD36+ EPCs were analyzed 48 hrs p.i. Replicated 
viral genome (green) were detected by hybridization with a B19V-specific DNA probe labeled 
with fluorescein. B19V NS1 (red) was immunostained with anti-B19V NS1 antibody. Nuclei were 
stained using DAPI. Confocal images were taken at a magnification of 100 ×. (B-D) 
Immunofluorescence analysis of DDR in B19V-infected cells. At the indicated times p.i., 
mock- and B19V-infected CD36+ EPCs were co-immunostained with anti-B19V NS1 (red) and 
anti-γH2AX (green) (B), or with anti-B19V NS1 (red) and anti-p-RPA32 (green) (C). Confocal 
images in panels B&C were taken at a magnification of 40 ×. (D) Confocal images of the same 
48 hrs p.i. samples as in panels B&C, but at a magnification of 100 ×. HU-treated EPCs were 
used as positive controls for γH2AX and p-RPA32 staining. 
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ATM, ATR and DNA-PK are activated in B19V-infected EPCs. 
We next assessed which kinase pathway is activated in the B19V infection-associated 
DDR. Strikingly, we found that all three upstream kinases were phosphorylated, and the 
phosphorylated forms (green) localized to the B19V replication center (overlap with NS1, red; 
Fig. 2A). Specifically, we tested for the following markers: ATM phosphorylated on Ser1981, 
which typically responds to DSBs [38]; ATR phosphorylated on Ser428, which typically 
associates with SSBs and stalled replication forks [217]; DNA-PKcs phosphorylated on Ser2056, 
a form of the kinase known to be induced by DSBs [32]. The phosphorylation status of each 
protein was confirmed by immunoblotting with their respective antibodies (Fig. 2C, lane 3 and 
Fig. 2D, lane 2).   
To determine which of the three upstream kinases is responsible for H2AX and p-RPA32 
phosphorylation in B19V-infected EPCs, we blocked their kinase activities using a panel of 
pharmacological inhibitors that inhibit their phosphorylation. Use of the inhibitors at the specified 
concentration did not result in any obvious cytotoxicity (data not shown). As shown in Fig. 2B, the 
levels of γH2AX and p-RPA32 were more than 10-fold higher in whole cell lysates of 
B19V-infected cells than in lysates of mock-infected counterparts (Fig. 2B, compares lanes 1 and 
2). Treatment with ATM-specific inhibitor KU55933 (at 10 μM) failed to cause a significant 
decrease in levels of γH2AX and p-RPA32 (Fig. 2B, compare lanes 2 and 4). However, treatment 
with the DNA-PK-specific inhibitor NU7441 (at 10 μM) reduced the levels of both by 
approximately (~) 60% (Fig. 2B, compare lanes 2 and 5). Notably, addition of the ATM and ATR 
pan-inhibitor CGK733 at 2.5 μM significantly decreased the levels of γH2AX and p-RPA32 (by 
more than 80%; Fig. 2B, compare lanes 2 and 3). The effectiveness of each inhibitors in 
preventing kinase phosphorylation was confirmed by Western blotting (Fig. 2C&D); KU55933 
and NU7441 inhibited specifically the phosphorylation ATM and DNA-PK, respectively (Fig. 2C, 
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compare lanes 3 and 5; Fig. 2D, compare lanes 2 and 3), and CGK733 inhibited the 
phosphorylation of both ATM and ATR (Fig. 2C, compare lanes 3 and 4). Although an 
ATR-specific inhibitor is not available, the fact that specifically inhibiting ATM using KU55933 did 
not affect γH2AX and p-RPA32 expression, whereas inhibiting both ATR and ATM using 
CGK733 resulted in significantly reduced expression, suggests that ATR signaling is the major 
determinant of   B19V infection-induced DDR, and that ATM does not play a major role in spite 
of its activation within the B19V DNA replication center. Moreover, our analysis suggests that the 
DNA-PK pathway also contributes to triggering of the DDR. 
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Figure 2. All three upstream kinases of the DNA repair pathways are activated in response 
to B19V infection of CD36+ EPCs. 
(A) Immunofluorescence analysis. At 48 hrs p.i., mock- and B19V-infected CD36+ 
EPCs were co-immunostained with anti-B19V NS1 (red) and anti-p-ATM (geen), anti-p-ATR 
(green) or anti-p-DNA-PKcs (green). Confocal images were taken at a magnification of 100 ×. 
(B-D) Western blot analysis. CD36+ EPCs were treated with DMSO and the indicated inhibitors 
for 3 hrs prior to infection with B19V. Cells were harvested at 48 hrs p.i., lysed, and 
immunoblotted with anti-γH2AX and anti-p-RPA32 (B), anti-p-ATM and anti-p-ATR (C) or 
anti-p-DNA-PKcs (D). In all blots, anti-β-actin was used as a loading control. HU-treated cells 
were used as a positive control for the DDR.      
 
 
 
 
 
 
 
80 
 
The ATR and DNA-PK signaling pathways are required for efficient B19V DNA replication 
in EPCs. 
We and others have reported that DDR induced during infection by autonomous 
parvoviruses facilitates replication of the viral genome [29,30,112]. To determine whether this is 
true for B19V, we used flow cytometry to examine the effects of the DDR kinase inhibitors on the 
percentage of B19V-infected (NS1-expressing) cells. We found that the percentage of 
NS1-expressing cells was reduced by 60% when cells were treated with CGK733 (inhibitor of 
ATM and ATR) and ~25% when the cells were treated with NU7441 (inhibitor of DNA-PK), but 
was unaffected when the cells were treated with KU55933 (inhibition of ATM; Fig. 3A). In 
addition, treatment with 1 mM caffeine, another pharmacological inhibitor of ATM and ATR 
signaling [218], resulted in a 50% reduction in B19V-infected EPCs (Fig. 3A, Caffeine). 
Considering the importance of NS1 during parvovirus replication, we speculate that B19V DNA 
replication is impaired when the DDR signal is blocked as a consequence of ATR and DNA-PK 
pathway signaling.   
We next performed Southern blot analysis to examine whether interference with DDR 
signaling impairs replication of the B19V genome. As shown in Fig. 3B, the levels of both 
replicative form DNA (RF DNA) and the ssDNA genome were significantly reduced by in 
B19V-infected EPCs that had been treated with CGK733 and caffeine, but not in those that had 
been treated with KU55933. Treatment with 2.5 μM CGK733 decreased B19V DNA forms 
~3-fold, and treatment with 10 μM NU7441 reduced the RF DNA and ssDNA by ~30% (Fig. 3B). 
We further knocked down ATM, ATR and DNA-PKcs by transducing cells with lentiviruses 
expressing specific shRNAs. As shown in Fig. 3C, the efficiency of knockdown using these 
lentivirus-based shRNAs was high. We selected transduced cells based on the expression of 
GFP (encoded by the lentiviral vector), and found that the percentage of NS1-expressing cells in 
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the ATR-knockdown group was reduced by 50%, and in the DNA-PKcs group it was reduced by 
27% (Fig. 3D). Taken together, the kinase inhibitor and knockdown results demonstrate that the 
ATR and DNA-PK signaling pathways contribute significantly to efficient B19V DNA replication. 
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Figure 3. Inhibition of ATR and DNA-PK signaling reduces B19V replication. 
(A&B) Effects of treatment with pharmacological inhibitors. CD36+ EPCs were 
treated with the indicated inhibitors for 3 hrs prior to B19V infection. (A) Flow cytometry 
analysis. At 48 hrs p.i., mock- or B19V-infected cells were immunostained for intracellular B19V 
NS1, and analyzed by flow cytometry. Numbers indicate the percentages of cells expressing 
NS1 in each case. A representative result is shown. Bar graph shows statistical analysis with 
average and standard deviation based on at least three independent experiments, with the 
percentage of NS1-expressing cells in the DMSO-treated group being arbitrarily set as 100; 
relative percentages of NS1-expressing cells in the other groups are indicated. (B) Southern 
blot analysis. At 48 hrs p.i., half of the cells were collected for Hirt DNA extraction and analyzed 
by Southern blotting with a B19V DNA-specific probe (upper blot). The other half of each sample 
was used for Western blotting with the anti-β-actin antibody, which served as a loading control 
(lower blot). Bands representing replicative form DNA (RF DNA) and single-stranded DNA 
(ssDNA) are indicated. B19V full-length DNA digested from pB19-M20 [202] was used as a 
marker. (C&D) Effects of treatment with kinase targeted shRNAs. CD36+ EPCs were 
transduced with shRNA-expressing lentiviruses, as indicated, at 48 hrs prior to infection. (C) 
Western blot analysis. At 48 hrs p.i., cells were collected and analyzed by Western blotting 
using the indicated antibodies. (D) Flow cytometry analysis. At 48 hrs p.i., cells were collected 
and analyzed for NS1 expression by flow cytometry, using anti-B19V NS1. Transduced 
(shRNA-expressing) cells were selected based on GFP positive population, and the percentages 
of NS1-expressing cells among the GFP-positive population are shown in each histogram. A 
representative result is shown. Statistical analysis from three independent experiments is also 
shown; the percentage of NS1-expressing cells in the shScrambled-transduced group was 
arbitrarily set as 100, and the relative percentages of NS1-expressing cells in other groups are 
indicated.  
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The ATR substrate Chk1 and the DNA-PKcs binding complex Ku70/Ku80 are required for 
B19V DNA replication in EPCs. 
Given that ATM, ATR and DNA-PKcs were activated and also localized to the B19V 
replication center, we questioned whether their activated substrates or components also 
localized to this site. To answer this question, we examined the localization of: 
Ser345-phosphorylated Chk1 (p-Chk1), an ATR substrate; Thr68-phosphorylated Chk2 
(p-Chk2), an ATM substrate [105,107,219,220]; and the Ku70/Ku80 heterodimer, which recruits 
DNA-PKcs and is part of the active DNA-PK holoenzyme [221]. As shown in Fig. 4A, Chk1 and 
Chk2 were phosphorylated and localized with NS1 within the nuclei of B19V-infected EPCs. 
Notably, although both Ku70 and Ku80 were evenly distributed across the nuclei in uninfected 
cells, they localized to the B19V replication center in infected cells (Fig. 4A, Ku80 and Ku70). 
These results confirmed that all the three signaling pathways (ATM-Chk2, ATR-Chk1, and 
DNA-PKcs-KU70/80) were activated in the B19V replication center. 
We used Chk1- and Chk2-specific pharmacological inhibitors to further explore the roles 
of the ATR and ATM pathways in B19V DNA replication. The efficiency of each inhibitor was 
confirmed by flow cytometry, following staining for the phosphorylated, active forms of these 
proteins (Fig. 4B). Compared to cells in the mock group, those infected with B19V expressed 
~4-fold more p-Chk1 and p-Chk2, as determined by the mean immunofluorescence intensity 
(MFI). When Chk1 and Chk2 inhibitors were applied, cell proliferation was not affected (data not 
shown) although the phosphorylation of Chk1 and Chk2 was inhibited by ~60-70%. Notably, only 
the inhibition of Chk1 led to reduced NS1 expression (~40% reduction; Fig. 4C). Consistent with 
this finding, application of the Chk1 inhibitor resulted in a ~70% decrease in replication of B19V 
genome, whereas application of the Chk2 inhibitor did not result in a significant  change, relative 
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to that in cells treated with DMSO (Fig. 4D). Taken together, these results demonstrate that 
Chk1, a direct substrate of ATR signaling, plays an important role in B19V DNA replication. 
To further examine the role of DNA-PK, we knocked down Ku70 by lentivirus-mediated 
shRNA. As shown in Fig. 4E, more than 70% of Ku70 was knocked down in shKu70-transduced 
EPCs compared with the scrambled shRNA control. Consequently, interference with Ku70 
resulted in more than 50% reduction of NS1 expression, again suggesting that DNA-PK signaling 
plays a role in B19V replication.     
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Figure 4. Inhibition of Chk1 and Ku70, but not Chk2, reduces B19V replication. 
(A)  Immunofluorescence analysis of localization of the substrates of ATR and 
ATM, and the DNA-PK components. At 48 hrs p.i., mock- or B19V-infected CD36+ EPCs were 
co-immunostained with anti-B19V NS1 (red) and one of the following: anti-p-Chk1 (green), 
anti-p-Chk2 (green), anti-Ku70 (green) or anti-Ku80 (green). Confocal images were taken at a 
magnification of 100 ×.  Nuclei were stained with DAPI. (B-D) Treatment with 
pharmacological inhibitors of Chk1 and Chk2. CD36+ EPCs were treated with DMSO, a Chk1 
inhibitor or a Chk2 inhibitor for 3 hrs prior to infection. (B) Flow cytometry analysis of p-Chk1 
and p-Chk2 expression. At 48 hrs p.i., cells were stained for intracellular p-Chk1 and p-Chk2, 
and analyzed by flow cytometry. The Mean Fluorescence Intensity (MFI) is indicated. 
Background sample was treated with second antibody only. (C) Flow cytometry analysis of 
NS1 expression. At 48 hrs p.i., cells were stained for intracellular NS1, and analyzed by flow 
cytometry. Numbers show percentages of NS1-expressing cells in the population. A 
representative result is shown. Statistical analysis from three independent experiments is also 
shown. The percentage of NS1-expressing cells in the DMSO-treated group was arbitrarily set 
as 100; the values shown for the other cells are relative to the DMSO control. (D) Southern blot 
analysis. At 48 hrs p.i., Hirt DNA was extracted from one half of the cells and analyzed by 
Southern blotting (upper panel); the remaining cells were used for Western blot analysis with 
anti-β-actin, which served as a loading control (lower panel). (E) Effect of treatment with 
Ku70-speciifc shRNA. CD36+ EPCs were transduced with lentiviruses expressing scrambled or 
Ku70-specifc shRNA, at 48 hrs prior to infection. At 48 hrs p.i., cells were collected and analyzed 
for NS1 expression by flow cytometry. Transduced (shRNA-expressing) cells were selected 
based on GFP positive population, and the percentages of NS1-expressing cells among the 
GFP-positive population are shown in each histogram. A representative result is shown. Western 
blot analysis at the bottom indicates knockdown efficiency of Ku70 in treated cells at 48 hrs p.i. 
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Inhibition of DDR signaling does not rescue B19V infection-induced G2/M cell cycle 
arrest.  
DNA damage triggers biochemical pathways that arrest cell cycle progression [32,218]. 
Given that B19V infection of EPCs induces cell cycle arrest at the G2/M phase (Fig. 5A, DMSO) 
[100], we monitored cell cycle changes in response to infection-induced DDR in the presence of 
kinase inhibitors and kinase-specific shRNAs. We found that none of the inhibitors tested 
(KU55933, CGK733, NU7441, Chk1i and Chk2i) reduced the cell cycle arrest observed in 
B19V-infected cells (Fig. 5A, NS1+). Consistent with this finding, individual knockdown of ATM, 
ATR or DNA-PKcs failed to significantly change this phenotype (Fig. 5B, NS1+); in NS1-positive 
cells of both the treated and control groups, more than 90% of the cells were arrested at G2/M.  
When we looked at infection-associated cell cycle changes across the entire cell 
population, we observed that inhibiting either ATR signaling (whether by applying CGK733, 
caffeine, or Chk1 inhibitor, or an ATR-targeted shRNA) or DNA-PK signaling (by applying a 
DNA-PKcs or Ku70 shRNA) reduced the number of G2/M-arrested cells across the whole 
population of B19V-inoculated EPCs (both NS1+ and NS1-) by ~10-15% (Fig. 5A, Total). Since 
B19V NS1 induces G2/M cell cycle arrest in B19V-infected EPCs [100], we believe that this 
reduction is due to a general decrease in NS1 expression in all of the cells (Fig. 3B&4D). 
Collectively, these results suggest that during B19V infection of EPCs, a mechanism that 
is independent of DNA damage checkpoints regulates G2/M cell cycle arrest.   
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Figure 5. Inhibition of DDR signaling does not rescue the G2/M cell-cycle arrest 
associated with B19V infection. 
(A) Effects of pharmacological inhibitors of DDR kinases on cell cycle arrest. CD36+ EPCs 
were treated with DMSO or the indicated pharmacological inhibitor for 3 hrs prior to B19V 
infection, and the effects on the cell cycle were assessed by flow cytometry. (B) Effect of 
shRNAs targeting DDR kinases on cell cycle arrest.  Cells were transduced with the 
indicated shRNA-expressing lentiviruses 48 hrs prior to infection, and the effects on cell cycle 
were assesses by flow cytometry. At 48 hrs p.i., GFP-expressing cells were selectively gated for 
anti-B19V NS1 staining and followed by DAPI staining for cell cycle analysis. Cell cycle in mock, 
infected cells with (NS1+) or without NS1 gating (total) are shown. In each panel, the 
percentages of cells in the G1, S and G2/M phases, respectively, are indicated (top left). 
 
  
 
 
 
 
 
91 
 
Discussion 
In this study, we have demonstrated, for the first time, that infection of human primary 
EPCs by B19V leads to the phosphorylation of H2AX and RPA32, a hallmark of DDR, and that 
three DDR-mediating kinase pathways are activated. Nevertheless, only ATR-Chk1 signaling 
appears to have a strong influence on B19V DNA replication, with DNA-PKcs activation 
contributing to a lesser extent. We note that failure of ATM signaling to significantly influence 
B19V DNA replication and the induced DDR was surprising given the importance of this pathway 
in MVC- and MVM-induced DDR [29,30,112]. Finally, our results indicate that a 
DDR-independent checkpoint is responsible for the arrest of B19V-infected cells at the G2/M 
transition of the cell cycle.  
Several members of the family Parvoviridae have recently been shown to induce DDR. 
During infection by the autonomous parvovirus MVC and MVM, ATM signaling is activated and 
required for replication of the viral genome [29,30,112]; ATR signaling is also activated in 
MVC-infected cells, but is not essential for MVC DNA replication [30]. In the case of infection by 
AAV2, a member in genus Dependovirus of the family Parvoviridae, it is predominantly the 
DNA-PK pathway that is activated in the presence of adenovirus, although ATM is also activated 
to some extent [64,65]. Notably in cells inoculated with UV-inactivated AAV2, only the ATR-Chk1 
signaling is activated [76]. 
The DDR induced during B19V infection of primary human EPCs is unique in that all the 
three kinase pathways are activated. More importantly, B19V takes advantage of both the 
ATR-Chk1 and DNA-PK signaling pathways to promote replication of its genome. B19V contains 
an ssDNA genome with a long ITR of 383 nts at both ends, the gap between the two ends is 
quite large. This structure is a perfect trigger for the DDR, as the cellular DNA damage 
machinery recognizes the primered DNA as a SSB and activates ATR-mediated signaling [45]. 
In addition, parvovirus DNA replicates according to a strand-displacement model [114], 
 
92 
 
producing new ssDNA ends and mimicking SSBs. Thus, B19V DNA replication also contributes 
to ATR activation. Similarly, parvovirus DNA replication produces nicked DNA intermediates that 
could be recognized as a DSB [30], and may activate ATM and DNA-PK [32].   
We observed that regular cell cycle of EPCs was moderately disturbed by knockdown of 
DNA-PKcs and Ku70 (Fig. 5B), indicating the importance of DNA-PK complex in sustaining EPC 
proliferation. Indeed, it has been shown previously that functional inactivation of either Ku70 or 
Ku80 in human somatic cell lines is lethal, and inactivation of DNA-PK causes proliferation deficit 
[222]. However, this notion does not affect the results obtained from using DNA-PK specific 
inhibitor, which did not affect the cell cycle of EPCs. Thus, we believe that inhibition of B19V 
replication by knocking down DNA-PKcs and Ku70 is a combined effect of inhibiting DNA-PK 
signaling pathway and partially blockage of G1/S transition. 
DNA-PK, an enzyme that contributes to the repair of DSBs through nonhomologous end 
joining (NHEJ), plays an important role in persistence of recombinant AAV2 (rAAV2) in 
rAAV2-transduced tissues. It may exert its effects on promoting rAAV2 DNA circularization by 
recruiting Ku70 and Ku80, which bind directly to ITR structure of rAAV2 [67,68]. However, the 
role of DNA-PK in wild type AAV2 DNA replication is to recruit complex heterodimer Ku70 and 
Ku80 to the AAV2 ITR, which serves an origin of DNA replication, and facilitates AAV2 DNA 
replication in vitro [66]. Ku70 and Ku80 act in this context by executing their helicase activity, and 
as such function much like the MCM2-7 complex, to promote replication of the AAV2 DNA 
[66,223]. In the current study, we have shown during B19V infection, Ku70 and Ku80 are 
recruited to the B19V DNA replication center, likely as that also includes phosphorylated 
DNA-PKcs. Since the ITRs of B19V genome are identical, as is the case of those of the 
Dependovirus AAV2 [146], we speculate that the mechanism underlying DNA replication may be 
similar for these viruses, with Ku70 and Ku80 playing the same role.     
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The autonomous parvoviruses MVC and MVM hijack ATM signaling for their DNA 
replication [29,30,112]. Notably, infection by the autonomous parvovirus B19V activates 
ATM-Chk2 signaling. Both ATM and Chk2 were also recruited to the B19V DNA replication 
center; however, this activation had no significant effects on replication of the B19V genome. The 
structures of the MVC and MVM genomes are very similar; each contains a T-shaped 
palindromic repeat at the left end, and a U-shaped palindromic repeat at the right hand 
[118,146]. This could explain why they would use a similar DDR-based strategy to replicate their 
DNA. ATM activation during MVC infection activated p53, which is responsible for MVC 
infection-induced apoptosis [30]. Notably, p53 was phosphorylated during B19V infection of 
EPCs [100]. Thus, we speculate that the ATM-Chk2 activation may contribute to apoptosis of 
B19V-infected EPCs.         
ATR signaling is responsible for the repair of SSBs and that associated stalled replication 
forks. Activation of its direct substrate, Chk1, results in slowed firing at the replication origin, and 
controls cell cycle arrest, replication fork stability and replication fork restart [217]. During 
parvovirus replication, NS1 creates a nick site at the terminal resolution site on the ITR [212], and 
the viral DNA undergoes replication according to a strand-displacement model [114], producing 
additional ssDNA ends that mimic SSBs structurally. Such events occur on multiple copies of the 
replicating B19V genome, and possibly trigger robust ATR activation. This leads to recruitment of 
ATR-dependent substrates (e.g., RFC, RPA32, MCM2-7, MCM10, PCNA and several DNA 
polymerases) to, or possibly their stabilization at, the replication fork [217]. Notably, the 
ATR-substrates also are important for AAV2 replication. A study involving an in vitro 
reconstitution assay has shown that RFC, PCNA, MCM2-7, polymerase δ and Rep78 are the 
minimum proteins required for efficient DNA replication of AAV2 [224,225]. In addition, one study 
revealed that infection with UV-inactivated AAV2 activates ATR-Chk1 signaling, and that 
activated ATR-Chk1 complexes then recruited polymerase δ to the AAV2 ITR by the 
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ATR-dependent substrates [76]. Unfortunately, it was not feasible to examine the role of this 
recruitment in AAV2 DNA replication in that study, since the genome of UV-inactivated AAV2 
was crosslinked [76]. We have shown that ATR can phosphorylate both RPA32, a 
single-stranded DNA binding protein, that is directly involved in replication of eukaryotic cells, 
and MCM2 (data not shown), a helicase that initiates formation of the pre-replication complex. 
However, additional investigation will be required to understand the mechanism by which 
ATR-Chk1 signaling promotes B19V DNA replication.    
DDR can lead to three distinct outcomes. When damage is severe and irreversible, the 
host cell may undergo apoptosis [226,227]. In the context of mild damage, it may recruit the 
repair machinery, through either non-homologous end joining (NHEJ) or mechanism involved in 
homologous recombination, and cell cycle arrest [32,228]. Our analysis of the effects of DNA 
repair pathway inhibitors that significantly reduced B19V DNA replication failed to detect a 
change in cell cycle pattern in infected cells. Moreover, although caffeine treatment caused a 
slight G1 arrest of the cell cycle in EPCs, it also failed to rescue the G2/M arrest in NS1+ cells. In 
addition, inhibiting Chk1 and Chk2 failed to interfere with G2/M cell cycle arrest in NS1+ cells, 
although these proteins normally function as checkpoint controls, regulating the cell cycle under 
stressful conditions [105,107]. Consistent with these findings, knockdown of ATM, ATR and 
DNA-PKcs did not affect B19V infection-induced G2/M arrest. All these lines of evidence strongly 
suggest that B19V infection-induced G2/M arrest is dependent on a DDR-independent cell cycle 
checkpoint. Indeed, it has been shown that B19V NS1 per se is able to arrest NS1-expressing 
cells at G2/M by deregulating E2F family transcription factors [100]. However, we cannot rule out 
the possibility that the ATR-Chk1 checkpoint, as well as the ATM-Chk2 checkpoint may be 
redundant with the E2F-mediated checkpoint in arresting cells at G2/M during B19V infection of 
EPCs. We are currently investigating this possibility.      
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In conclusion, we have identified a de novo role for ATR-Chk1 and DNA-PK signaling in 
B19V DNA replication in primary human EPCs. Components of these pathways can be explored 
as candidate drug targets for inhibiting B19V replication, and for the treatment of B19V-asociated 
diseases in patients infected with B19V. 
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Chapter 4 
ATM signaling facilitates autonomous parvovirus DNA replication 
through SMC1-mediated intra-S phase arrest 
 
 
 
Abstract 
Activation of a host DNA damage response (DDR) is essential for DNA replication of 
Bocavirus minute virus of canines (MVC); however the mechanism by which DDR contributes to 
viral DNA replication is unknown. In the current study, we demonstrate that MVC infection 
triggers the intra-S phase arrest to slow down host cellular DNA replication and to recruit cellular 
replication factors for viral DNA replication. The intra-S phase arrest is regulated by ATM 
(ataxia-telangiectasia-mutated) signaling in a p53-independent manner. Moreover, we 
demonstrate SMC1 (structural maintenance of chromosomes 1) as the key regulator of the 
intra-S phase arrest induced during infection. Either knockdown of SMC1 or complementation 
with a dominant-negative SMC1 mutant blocks both the intra-S phase arrest and viral DNA 
replication. Finally, we show that the intra-S phase arrest induced during MVC infection was 
neither caused by damaged host cellular DNA nor by viral proteins, but by replicating viral 
genomes physically associated with the DNA damage sensor, the Mre11-Rad50-Nbs1 (MRN) 
complex. In conclusion, the feedback loop between MVC DNA replication and the intra-S phase 
arrest is mediated by the ATM-SMC1 signaling and plays a critical role in MVC DNA replication. 
Thus, our findings unravel the mechanism underlying DDR signaling-facilitated MVC DNA 
replication, and demonstrate a novel strategy of DNA virus-host interaction. 
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Introduction 
Parvoviruses are small, non-enveloped and single-stranded DNA (ssDNA) viruses, and 
cause highly contagious diseases that are sometimes fatal in humans and animals [2,201]. The 
viral genome of parvoviruses is 5-6 kilobases (kb) and flanked by two terminal hairpin structures. 
Adeno-associated viruses (AAVs), in genus Dependovirus of the family Parvoviridae, require 
helper virus for replication, whereas autonomous parvoviruses, such as minute virus of mice 
(MVM) and minute virus of canines (MVC), in genera Parvovirus and Bocavirus, respectively, 
replicate autonomously in host cells. Because of its well-characterized reverse genetics system 
and efficient infection system, MVC has been used as a model to study the DNA replication 
mechanism of autonomous parvoviruses as well as the pathogenesis of bocavirus infection 
[30,118,121]. During infection of Walter Reed/3873D (WRD) canine cells, MVC induces a 
gradual cell cycle arrest, from S phase in early infection to G2/M phase at a later stage, and 
mitochondria-mediated apoptosis [121]. Additionally, MVC hijacks the cellular DNA damage 
response (DDR) machinery to facilitate viral DNA replication [30]. The MVC genome shares 
50-60% identity with the genome of human bocavirus type 1 (HBoV1) [118,229], a newly 
identified human pathogen that causes acute respiratory tract infections in children worldwide 
[124,229–233]. Therefore, MVC has been used as a model for studying bocavirus replication. 
Infections of many DNA viruses are able to subvert the cellular DDR machinery 
[49,51,81,234], a safeguarding system triggered by damaged cellular DNA structures such as 
ssDNA breaks (SSBs), double-stranded DNA breaks (DSBs) and stalled replication forks 
[32,180]. The central role of the DDR is to protect genome stability and integrity through a 
cascade of phosphorylation events initiated by three phosphatidylinositol 3-kinase-like kinases 
(PI3Ks), ATM (ataxia telangiectasia-mutated kinase), ATR (ATM- and Rad3-related kinase), and 
DNA-PKcs (DNA-dependent protein kinase catalytic subunit) [34,35]. In the presence of 
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damaged DNA structures, these three kinases are recruited and auto-phosphorylated, and 
further recruit a number of effector proteins to coordinate cell cycle arrest, DNA repair, and 
apoptosis. ATM signaling has been reported to be co-opted by many DNA viruses, including 
autonomous parvoviruses MVC and MVM [29,30,112], papillomaviruses [179,235], and herpes 
viruses [71,236–239], to help their productive infections. However, the beneficial effects of ATM 
signaling on viral DNA replication have not been well-understood [49–51]. 
In replicating cells in S phase, one of the most important outcomes of the DDR is the 
intra-S phase arrest [145,240,241]. The intra-S phase arrest plays a crucial role in preventing 
damaged DNA to enter mitosis by slowing the rate of S phase progression and stabilizing stalled 
replication forks [145,242]. The signaling proteins involved in the intra-S phase arrest include a 
large number of checkpoint proteins and DNA repair factors. Intra-S phase checkpoint proteins 
are activated to slow down cellular DNA replication through degradation of replication proteins or 
regulator factors such as Cdc25A [241,243–247], while DDR signaling recruits repair factors to 
the damaged DNA foci for the rapid resumption of replication following DNA repair [248]. ATM 
signaling plays a central role in regulating DSB-induced intra-S phase arrest. Damaged DNA is 
first recognized by the Mre11-Rad50-NBS1 (MRN) complex sensor and further recruits ATM 
kinase. Following ATM autophosphorylation, several proteins such as Chk2 (checkpoint protein 
2), BRCA1 (breast cancer type 1 susceptibility protein) and SMC1 (structural maintenance of 
chromosomes 1) are phosphorylated and recruited as checkpoint proteins [145]. SMC1 was 
originally identified as a subunit of the cohesion complex that ensures proper segregation of 
sister chromatids [249]. Further studies confirmed that it is an intra-S phase checkpoint protein 
that is phosphorylated at serines 957 and 966 by ATM kinase [163,250–253]. However, it is not 
clear how SMC1 interferes with cellular DNA replication proteins or regulator factors through its 
checkpoint function. Although replication of many DNA viruses occurs during the S phase of host 
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cells and induces a DDR, the link between viral infection-induced DDR and the intra-S phase 
arrest has not been well-established. 
Modulation of the host cellular environment through cell cycle control is an important 
strategy for replication of DNA viruses. By arresting cells in S phase, viral DNA synthesis is 
facilitated by the cellular DNA replication machinery; however, many DNA viruses also block 
cellular DNA synthesis for productive infection [254–256]. Autonomous parvovirus MVM has 
been reported to inhibit host cell growth through p53-dependent inhibition of cyclin A, and the 
large nonstructural protein NS1 plays a key role in inhibiting host cell DNA synthesis [16,17,113]. 
However, we found that expression of the non-structural proteins of MVC, NS1 and NP1, failed 
to interfere with host cell cycle regulation [121], indicating that a mechanism without a direct 
involvement of viral proteins is involved in MVC-induced cell cycle arrest. 
In this study, we aim to determine whether DDR signaling and cell cycle modulation 
coordinate to facilitate MVC DNA replication. Our results confirm that MVC infection triggers the 
intra-S phase arrest that is mediated by the ATM-SMC1 pathway and facilitates viral DNA 
replication. Moreover, our results provide direct evidence that MVC infection-induced DDR is 
elicited by the MRN complex that senses replicating viral genomes. These findings reveal a 
novel strategy by which MVC exploits cellular DNA replication and DDR machineries for its own  
DNA replication, and provide new insights in the mechanisms of virus-host interaction that 
directly contribute to viral DNA replication. 
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Materials and Methods 
Cell culture and virus infection.  
WRD cells [120] were maintained in Dulbecco’s modified Eagle’s Medium (DMEM) with 
10% fetal calf serum (FCS) in 5% CO2 at 37°C. MVC (GA3 strain) was cultured and titrated as 
previously described [30,118,121]. WRD cells were infected with MVC at a multiplicity of 
infection (MOI) of 3. Both WRD cells and MVC were gifts from Collins Parrish at Cornell 
University). 
 
Chemicals and treatment.  
ATM kinase Inhibitor KU55933 (Tocris Bioscience, Bristol, UK) was prepared in dimethyl 
sulfoxide (DMSO) as a stock solution at 10 mM. Bromodeoxyuridine (BrdU; Sigma) was diluted 
in deionized water as a stock solution at 10 mM. WRD cells were seeded on 60-mm dishes 1 day 
prior to chemical treatment. KU55933 was applied to cells at a final concentration of 10 µM upon 
virus infection.   
 
Antibodies used. 
The rat anti-MVC NS1 polyclonal antibody was developed previously [118]. All the other 
antibodies used in this study were purchased from companies listed as follows: anti-BrdU and 
anti-PCNA antibodies (BD Biosciences, San Jose, CA), anti-γH2AX antibody (Novus, Littleton, 
CO), and anti-Rad50 (Epitomics, Burlingame, CA), anti-p-p53(Ser15) and anti-Flag epitope (Cell 
signaling, Danvers, MA), anti-β-actin (Sigma,), anti-cyclin A, anti-RFC1, anti-pol δ and 
anti-Mre11 antibodies (Santa Cruz Biotechnology, Santa Cruz, CA), anti-p-Nbs1(Ser343) and 
 
101 
 
anti-p-SMC1(Ser957) antibodies (Genscript, Piscataway, NJ), and anti-SMC1 antibody 
(Genetex, Irvine CA). All the secondary antibodies were purchased from Jackson 
ImmunoResearch Laboratories, Inc. (West Grove, PA). 
 
siRNA, plasmids, and transfection.  
Small interfering RNA (siRNA) oligonucleotides were synthesized as dicer substrate RNA 
interference (RNAi) at Integrated DNA Technologies (IDT, Coralville, IA). The following siRNA 
sequences were chosen for targeting the genes of interest: siRNA specific to canine ATM 
(siATM), 5’-GUA CUA GUU GCU UGU GUA ACU GUA-3’; siRNA specific to canine SMC1A 
(siSMC1), 5’-CUC UCC CAA UCU CUG GAU AUU UGG-3’; siRNA specific to canine p53 
(sip53), 5’-CCA CCA UCC CUA AAC UAA UGT G-3’. The following scrambled RNA (scrambled) 
was used as an siRNA control: 5’-CUU CCU CUC UUU CUC UCC CUU GUG A-3’. Transfection 
of all siRNAs was performed using Hiperfect reagent (Qiagen, Valencia, CA) following the 
manufacturer’s instructions. At 48h post-transfection, the cells were fed with fresh medium and 
infected with MVC.  
Plasmids pcDNA3-5’cMyc-SMC1wt and pcDNA3-5’cMyc-SMC1(S957A/S966A) [250],  
expressing wild-type human hSMC1wt and hSMC1(S957A/S966A) mutant, respectively, were 
purchased from Addgene (Cambridge, MA). MVC plasmids pIMVC, pIMVCNP1(-), 
pIMVCVP1/2(-), and pMVCNSCap and control vector pBB have been described previously [118]. 
Nucleofection was used to transfect plasmid DNA using an AMAXIA Nucleofector (Lonza In., NJ) 
at program T030. 
 
Southern blot analysis.  
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Low molecular weight (Hirt) DNA was extracted from infected cells [257,258] and 
analyzed by Southern or Dot blotting using an MVC NSCap probe as described previously 
[30,118,121]. 
 
BrdU incorporation and BrdU pulsing assays. 
For BrdU incorporation assay [102], BrdU was added to the cell culture medium at the 
final concentration of 30 μM and incubated for 1h. After BrdU incorporation, cells were collected, 
fixed in 3.7% paraformaldehyde for 30 min and permeabilized with 0.1% Triton X-100 for another 
30 min. After permeabilization, two procedures were followed to differentiate the cell cycle 
(cellular DNA replication) from viral DNA replication. For the detection of the cell cycle, cells were 
treated with 1 M HCl for 30 min to denature chromosome DNA for the binding of the BrdU 
epitopes with an anti-BrdU antibody (clone B44) [259]. For viral DNA replication analysis, the HCl 
treatment step was skipped [260] since parvovirus replication generates ssDNA viral genome a 
well as replication intermediates that contain partial ssDNA [114]. The cells were co-stained with 
anti-BrdU and anti-MVC NS1 antibodies followed by secondary antibodies and DAPI to analyze 
the cell cycle and the percentage of NS1-positive (NS+) cells, respectively. 
For the BrdU pulsing assay, at 18h p.i., mock- or MVC-infected cells were incubated with 
BrdU at 30 μM for 20 min. Incubated cells were collected immediately after BrdU labeling and 
every hour thereafter. Collected cells were fixed, permeabilized and treated with 1 M HCl as 
described above. Treated cells were then co-stained with DAPI and anti-BrdU and anti-MVC 
NS1 antibodies, and were assessed by flow cytometry. Mock- and MVC-infected cells were 
gated according to NS1 staining, and the change in DNA content in the BrdU-labeled cells was 
monitored by DAPI staining. 
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Flow cytometry analysis. 
The above stained cell samples were analyzed on a three-laser flow cytometer (LSR II; 
BD Biosciences) at the Flow Cytometry Core of the University of Kansas Medical Center. All flow 
cytometry data were analyzed using FACSDiva software (BD Biosciences). 
 
Comet assay.  
A Comet assay kit was purchased from Cell Biolabs Inc. (San Diego, CA) and used 
according to the manufacturer’s instructions. Briefly, at 18h p.i., mock- or MVC-infected cells 
were trypsinized and diluted in PBS. Mock-infected cells were treated with 100 μM H2O2 at 4ºC 
for 20 min as positive controls. Mock- and MVC-infected, and H2O2-treated cells were mixed 
with 1% low melting-point agarose, respectively, and coated on slides. Then, the slides were 
treated in an alkaline condition, electrophoresed and stained with the VISTA green dye. Stained 
slides were visualized under a confocal microscope (Eclipse C1 Plus, Nikon, Melville, NY) with 
Nikon EZ-C1 software. Images were taken at a magnification of ×40. 
 
BrdU-based dot blot analysis of DNA replication. 
WRD cells were mock- or MVC-infected. At 12h, 18h, 24h and 48h p.i., the infected cells 
were collected. Half of the cells were used to purify total DNA (both genomic DNA and viral DNA) 
using the DNeasy Blood & Tissue Kit (Qiagen). The other half of the infected cells were used to 
extract low molecular weight DNA (viral DNA) using the Hirt DNA extraction method [257,258]. 
Extracted DNA was diluted in 100 µl of deionized water. The BrdU-based dot blot assay was 
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performed as previously described [261]. Briefly, to expose the BrdU epitopes in cellular DNA, 
the DNA samples were denatured by heating at 95ºC for 5 min and immediately kept on ice; 5 µl 
of the DNA samples were pipetted onto a nitrocellulose membrane. The DNA on the membrane 
was cross-linked by UV treatment at a dose of 700 mJ/cm2 in a Hoefer UVC 500 UV cross-linker 
(Hoefer, Inc., Holliston, MA). The membrane was then blocked in 5% non-fat milk in TBST 
(Tris-buffered saline, pH 7.4, with 0.1% Tween 20) at room temperature, after which a Western 
blotting procedure was followed. 
 
Western blotting and immunofluorescence staining.  
Western blotting was performed as previously described [30,121]. Immunofluorescence 
staining was performed as previously described [30,212]. Briefly, cells were fixed in 3.7% 
paraformaldehyde and permeabilized in 0.1% Triton X-100, except for the staining with an 
anti-PCNA antibody, in which 90% methanol was used. Images were taken at a magnification of 
×100 or ×40 under a confocal microscope (Eclipse C1 Plus, Nikon) with Nikon EZ-C1 software. 
 
BrdU-based immunoprecipitation (IP) assay. 
At 18h p.i., mock- or MVC-infected cells were pulsed with BrdU at 100 µM for 1h and 
collected. IP was performed using the Pierce Crosslink IP kit (Thermo Scientific, Rockford, IL). 
Briefly, treated cells were lysed and centrifuged; the supernatant that contained viral DNA was 
incubated with protein A/G-coated resins pre-incubated with an anti-BrdU antibody. The resins 
were then rinsed and diluted in protein loading buffer followed by Western blotting using an 
anti-Mre11 antibody. 
 
105 
 
Results 
MVC DNA replication arrests host cells in S phase during early infection. 
We have shown previously that MVC infection induces a host cell cycle change from S 
phase in early infection to G2/M phase in later infection [121]; however, whether such a change 
is related to viral DNA replication is unknown. To determine the relationship between viral and 
cellular DNA replication, we performed a BrdU pulse labeling assay. BrdU is a thymidine analog 
that can be incorporated into replicating DNA [260,262]. For the detection of cellular DNA 
replication by BrdU incorporation, a denaturation process, such as treatment with hydrochloride 
(HCl), is necessary because the BrdU epitopes are only detectable in a ssDNA form by the 
monoclonal anti-BrdU antibody (B44 clone) [259]. As anticipated, without denaturation, 
incorporated BrdU was undetectable in mock-infected cells (Fig. 1A, -HCl). In contrast, 
MVC-infected cells showed punctate foci of anti-BrdU staining that co-localized with the foci 
stained for MVC NS1 (Fig. 1A, -HCl), which represent active viral DNA replication centers. Thus, 
denaturation is not necessary for the detection of parvoviral ssDNA synthesis in this assay as 
previously reported for replication of parvovirus Aleutian mink disease virus (AMDV) [260]. This 
is presumably because parvovirus DNA replication generates replicative intermediates that 
contain partial ssDNA and viral ssDNA genome [114]. Notably, with denaturation, both mock- 
and MVC-infected cells showed a much broader distribution of BrdU-incorporated foci, which 
presumably contained both newly synthesized cellular DNA and both dsDNA and ssDNA forms 
of viral DNA (Fig. 1A, +HCl).  
To determine the relative levels of incorporated BrdU in cellular DNA vs. viral DNA under 
the denaturation condition, total DNA and lower molecular weight DNA (Hirt DNA) of infected 
cells were extracted, respectively, from equal numbers of cells, and were analyzed by a dot blot 
assay. Incorporated BrdU in Hirt DNA of MVC-infected cells was detected at a background level 
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as that seen in Hirt DNA of mock-infected cells (Fig. 1B, Hirt DNA), except for the Hirt DNA 
prepared from MVC-infected cells at 18h post-infection (p.i.; Fig. 1B, arrow), suggesting a peak 
of viral DNA replication. At this peak, the incorporation of BrdU into Hirt DNA was over 20 times 
lower than that into cellular DNA (Fig. 1B, 18h). Notably, the Hirt DNA samples contained nearly 
all the viral DNA in the total DNA of MVC-infected cells (Fig. 1C), and were contaminated only 
with a very low level of cellular DNA (Fig. 1B, 48h/Mock). Hence, these results confirm that the 
majority of incorporated BrdU signaling resulted from cellular DNA replication in infected cells. In 
following studies, denaturation of infected cells was used to differentiate cellular DNA replication 
from viral DNA replication.  
The cell cycle change was then examined in MVC-infected cells. At all the times points 
p.i., approximately 36% of NS1-negatvie cells (NS1-) were in S phase (Fig. 2A, NS1-). At 12h 
p.i., MVC-infected (NS1+) cells showed 81% in S phase. The majority of these NS1+ cells were 
actually in early S phase as shown by a lower DNA content (Fig. 2A, NS1+/12h). NS1+ cells 
progressed to mid-S phase at 18h p.i. and late S phase at 24h p.i. (Fig. 2A, NS1+/18h and 24h). 
At 48h p.i., viral DNA replication slowed down; only 16% of NS1+ cells were in S phase, and the 
majority of NS1+ cells had moved to G2/M phase (Fig. 2A, NS1+/48h). A statistical analysis of 
the cell cycle over the course of MVC infection was summarized (Fig. 2B). Overall, MVC infection 
induced 80% of NS1+ cells in S phase from 12h to 24h p.i. but only 35-37% of mock-infected 
cells.   
We next detected BrdU incorporation in infected cells without denaturation to probe viral 
DNA replication. Approximately 40% of the total cell population produces a significant level of 
viral ssDNA/replication intermediates, which suggests active viral DNA replication, at 18h and 
24h p.i. At 48h p.i. viral DNA replication had slowed down to 9% of the total cell population, 
although most of the cells (approximately 72%) were MVC-infected as shown by NS1+ staining 
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(Fig. 2C). These results indicate that active viral DNA replication occurs from 18h to 24h p.i. (Fig. 
2D).  
Taken together, these results show that MVC infection induces accumulation of infected 
cells in S phase during early infection, which supports active viral DNA replication. Notably, we 
observed that at early infection (18h-24h p.i.), cellular DNA replication was active but at a lower 
rate (Fig. 1B, compare dots in lines between Mock and MVC for Total DNA), indicating that S 
phase progression was perturbed during early infection.   
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Fig. 1. Cellular DNA replication decreases, but still prevails over viral DNA replication 
during early infection of MVC. 
(A) Immunofluorescence analysis of DNA replication. WRD cells were seeded on 
chamber slides 24h prior to MVC infection. At 18h p.i., cells were incubated with BrdU for 1h. The 
cells on slides were fixed and treated with (+HCl) or without HCl (-HCl) as indicated. Fixed cells 
were co-stained with anti-MVC NS1 and anti-BrdU antibodies and DAPI. Confocal images were 
taken at a magnification of ×100. (B) Dot blot analysis of viral and cellular DNA replication. 
At the indicated times p.i., mock- or MVC- infected cells were incubated with BrdU for 1h. 
BrdU-labeled cells were collected and extracted for total DNA and Hirt DNA (lower molecular 
weight DNA), respectively. The DNA samples were denatured and dot blotted and 
immunostained with an anti-BrdU antibody. (C) Southern blot analysis of viral DNA in 
preparations of total DNA and Hirt DNA. The total DNA and Hirt DNA samples extracted from 
MVC-infected cells were denatured and dot blotted and hybridized with a 32p-lablled MVC 
NSCap probe [118]. 
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Fig. 2. MVC DNA replication arrests host cells in S phase. 
(A&B) Flow cytometry analysis of the cell cycle. (A) At the indicated times p.i., mock- 
or MVC-infected cells were BrdU-labeled, treated with HCl (+HCl), stained and analyzed by flow 
cytometry. Unlabeled mock-infected cells were used as a negative control for anti-BrdU staining. 
Both the NS1-positive (NS1+, marked in red) and negative (NS1-, marked in black) cell 
populations were gated. The percentage of cells in each phase was gated in the NS1+ and NS1- 
cell populations and in the whole population (whole) based on the intensity of BrdU staining and 
DNA content. Numbers show percentages of cells in S phase (upper) and G2/M phase (lower) in 
each histogram. Arrows indicate the most concentrated cell population. (B) The percentages of 
cells in S phase are shown as means (numbers) and standard deviations (error bars) and were 
generated from at least three independent experiments. P values were determined using 
Student’s t-test. (C&D) Flow cytometry analysis of viral DNA replication. (C) At the indicated 
times p.i., mock- or MVC-infected cells were incubated with BrdU for 1h. The cells were 
co-stained with anti-NS1 and anti-BrdU antibodies and DAPI, and analyzed by flow cytometry. 
NS1+ cells were marked in red. Numbers shown in the histograms indicate percentages of cells 
with BrdU incorporation from one representative experiment. (D) The percentages of BrdU+ cells 
are plotted to the time points p.i. Averages and standard deviations are shown at each time point 
on the right side, and were obtained from at least three independent experiments. 
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MVC DNA replication prolongs S phase. 
To further investigate whether S phase accumulation is due to a prolonged S phase 
progression, we performed a BrdU pulsing assay to analyze the rate of S phase progression.  
Immediately after labeling (0h post-labeling), infected cells (at 18h p.i.) with 2N, intermediate 
(Interm.) and 4N DNA contents were all labeled in the mock group for cellular DNA synthesis in 
early, mid and late S phase, respectively (Fig. 3C, Mock/0h). In contrast, the majority of the 
labeled infected cells had an intermediate DNA content immediately after labeling (Fig. 3C, 
MVC/0h), which was consistent with the cell cycle arrest in mid-S phase at 18h p.i. (Fig. 2A). 
Labeled mock-infected cells were able to synthesize DNA smoothly, as evidenced by the fast 
increase in cells with a 4N DNA content every hour post-labeling. At 5h post-labeling, 
approximately 90% of the cells had a DNA content of 4N. At 6h post-labeling, a large portion of 
cells finished mitosis and became 2N cells, indicating that those cells had finished one round of 
replication and the daughter cells had entered G1 phase (Fig. 3C, Mock). By contrast, 
MVC-infected cells synthesized DNA slowly as the increase in 4N cells was much slower than in 
the mock-infected group. At 12h post-labeling, only 55% of the labeled cells had a DNA content 
of 4N. All the labeled cells were not able to pass G2/M phase even after 24h post-labeling 
(approximately 48h p.i.). It took at least 12h for infected cells to move from early S to late S 
phase, suggesting that the S phase of MVC-infected cells is prolonged. 
Collectively, these results confirm that MVC DNA replication induces S phase arrest. 
Moreover, cellular DNA synthesis in MVC-infected cells is still active but slower, which is 
consistent with the fact that BrdU was less incorporated in MVC-infected cells than in 
mock-infected cells (Fig. 1B). Thus, we hypothesized that MVC infection creates a prolonged S 
phase to block cellular DNA replication and to facilitate viral DNA replication. 
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Figure 3. MVC replication delays host cell S phase progression. 
 (A) Diagram of BrdU pulsing assay. WRD cells were infected with MVC or 
mock-infected. At 18h p.i., infected cells were incubated with BrdU for 20 min. After removing 
BrdU, cells were taken every hour as indicated in panel C. The cells were treated with HCl and 
then co-stained with an anti-NS1 antibody, an anti-BrdU antibody and DAPI for flow cytometry 
analysis. (B&C) DNA content analysis. DNA content was gated as 2N, 4N, and intermediate 
(Interm.; between 2N and 4N) in unlabeled cells based on DAPI staining (B), which was used as 
a reference to gate labeled cells with 2N, 4N and intermediate DNA content (C). Numbers under 
histograms show percentages of the cell population in each gate.  
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MVC hijacks host cellular DNA replication factors for viral DNA replication. 
S phase is critical for parvoviruses to hijack the cellular replication machinery [5,11,13]. 
Previous studies on MVM and H-1 parvovirus have shown that the DNA replication factors PCNA 
(proliferating cell nuclear antigen), RFC1 (replication factor C 1), cyclin A, pol α and pol δ were 
recruited into the viral DNA replication compartments during infection [111,263]. Since MVC 
infection delays S phase progression, we assessed the localization of these DNA replication 
factors in the nuclei of infected cells. At 18h p.i., PCNA, RFC1, pol δ and cyclin A co-localized 
with MVC NS1 (Fig. 4A), suggesting that these replication factors were hijacked for viral DNA 
synthesis in the environment of prolonged S phase. Notably, the level of RFC1, a component of 
the clamp loader RFC complex that drives PCNA and polymerase loading onto the replication 
fork, disappeared gradually in the viral DNA replication centers during infection (Fig. 4A, RFC1). 
Western blot analysis confirmed that the total RFC1 level was significantly reduced at 18h and 
24h p.i. (Fig. 4B). The levels of other replication factors, such as cyclin A and PCNA, were also 
decreased but to a lesser extent than that of RFC1. 
Since ATM signaling-mediated intra-S phase arrest has been reported to be involved in 
inhibition of cellular DNA replication during S phase [163,250–253], and since  ATM signaling is 
also required for MVC replication [30], we assessed the protein levels of these replication factors 
in ATM-inactivated infected cells. The reduction in the replication factors was obviously 
diminished by an ATM-specific inhibitor, KU55933 [151] (Fig. 4B), indicating that the reduction is 
dependent on ATM signaling. 
Taken together, these results further confirm that S phase is required for MVC DNA 
replication. MVC infection not only creates a prolonged S phase environment for hijacking 
cellular DNA replication factors, but also reduces the overall levels of cellular DNA replication 
factors to inhibit cellular DNA synthesis. Since the reduction in replication factors was blocked by 
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an ATM-specific inhibitor, we hypothesized that ATM signaling may play a critical role in the 
inhibition of cellular DNA synthesis that contributes to the delay in S phase progression and to 
the intra-S phase arrest [145,241]. 
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Fig. 4. MVC hijacks host DNA replication factors for viral DNA replication. 
 (A) Immunofluorescence staining of cellular DNA replication factors. At 18h p.i., 
mock- and MVC-infected cells were fixed and stained with the indicated antibodies and DAPI. 
For RFC1 staining, infected cells were also analyzed at 12h and 24h p.i. (B) Western blot 
analysis of cellular DNA replication factors. Mock- and MVC-infected cells were either treated 
with ATM inhibitor KU55933 (ATMi) or DMSO control. At the indicated times p.i., the cells were 
collected and analyzed by Western-blot using antibodies against proteins as indicated.     
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ATM signaling regulates MVC infection-induced intra-S phase arrest. 
 To further examine the correlation between S phase arrest and ATM signaling, we 
pulse-chased infected cells with BrdU, and analyzed BrdU-labeled cells under denaturation for 
expression of γH2AX, which is induced by ATM activation during MVC infection [30]. As shown in 
Fig. 5A, nearly all γH2AX-positive cells were also BrdU-positive, suggesting that ATM activation 
correlates with the infection-induced S phase arrest, whereas treatment with an ATM-specific 
inhibitor blocked this correlation (Fig. 5A, MVC/ATMi). As a control, treatment with the ATM 
inhibitor did not change the cell cycle pattern in mock-infected cells (Fig. 5A, Mock/ATMi). 
To define the function of ATM signaling in the MVC infection-induced intra-S phase arrest 
better, we examined the cell cycle status of infected cells treated with the ATM inhibitor or DMSO 
(as a control). In ATM inhibitor-treated groups, the population of the cells in S phase was almost 
reduced to the level of mock-infected cells (Fig. 5B). Thus, inhibition of ATM signaling 
significantly blocked the infection-induced S phase arrest. These results strongly suggest that 
the S phase arrest, which occurs in replicating cells, is ATM activation-dependent. Hence, we 
conclude that the MVC infection-induced S phase arrest mimics the intra-S phase arrest elicited 
by cellular DSBs. Inhibition of the S phase arrest by the ATM inhibitor significantly blocked viral 
DNA replication (Fig. 5C), which is consistent with our previous observations [30]. 
Altogether, these results show that MVC infection-induced S phase arrest is regulated by 
ATM signaling, and is the intra-S phase arrest. Importantly, in addition to UV-, chemical- or 
irradiation-induced intra-S phase arrest, our results supply a de novo example that replication of 
a DNA virus is able to induce the intra-S phase arrest that plays an essential role in viral DNA 
replication. 
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Figure 5. MVC infection-induced S phase arrest is regulated by ATM signaling. 
(A&B) Flow cytometry analysis of DDR. WRD cells were infected with MVC or 
mock-infected, and were treated with ATMi or DMSO. At the indicated times p.i., the cells were 
incubated with BrdU for 1h. (A) Labeled cells were treated with HCl and then co-stained with 
anti-γH2AX and anti-BrdU antibodies for flow cytometry analysis. Numbers in each histogram 
show percentages of both BrdU- and γH2AX-positive cells. A cell cycle analysis of ATMi-treated 
mock-infected cells is shown on the right side. Treated cells were co-stained with an anti-BrdU 
antibody and DAPI. Numbers show percentages of cells in S phase (upper) and G2/M phase 
(lower), respectively. (B) Labeled cells were treated with HCl, then co-stained with an anti-BrdU 
antibody and DAPI for cell cycle analysis. The whole cell population in S phase, either treated 
with ATMi or DMSO, and mock-infected cells, was quantified at the indicated times p.i., and is 
shown as mean ± standard deviation. P values were determined using Student’s t-test. (C) 
Southern blot analysis of viral DNA replication. MVC-infected cells either treated with DMSO 
control or ATMi were collected for preparation of Hirt DNA at the indicated times p.i. Samples 
were analyzed by Southern blot. Mock-infected cells were used as a negative control.     
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MVC infection-induced intra-S phase arrest is p53-independent. 
ATM-dependent accumulation of p53 plays a pivotal role in regulating G1 phase arrest to 
block cellular DNA synthesis following DNA damage [264]. It has also been reported that p53 is 
involved in MVM NS1-mediated S phase arrest [17]. In addition, our previous study also showed 
that p53 was phosphorylated at serine 15 in the late stage of MVC infection [30]. To explore 
whether p53 activation plays a role in MVC infection-induced intra-S phase arrest, we assessed 
the cell cycle pattern and viral DNA replication of MVC-infected cells knocked down p53. We 
confirmed that p53 was phosphorylated at serine 15 at 18h p.i. (Fig. 6A). Transfection of either 
p53 siRNA or ATM siRNA reduced p53 phosphorylation to the background level (Fig. 6A), 
indicating that p53 was phosphorylated by ATM signaling during MVC replication. However, 
while knockdown of ATM significantly reduced the cell population in S phase, knockdown of p53 
did not change the cell population in S phase (Fig. 6B). In parallel, knockdown of ATM but not of 
p53 significantly blocked MVC DNA replication (Fig. 6C).  
Taken together, we conclude that p53 is not involved in MVC infection-induced intra-S 
phase arrest. This result is also consistent with the notion that p53 is not associated with the 
intra-S phase arrest induced by cellular DNA damage [145].  
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Figure 6. p53 is dispensable for MVC infection-induced S phase arrest. 
WRD cells were transfected with scrambled siRNA (siScrambled) control, ATM siRNA 
(siATM), and p53 siRNA (sip53), and then infected with MVC. (A) Western blot analysis of 
phosphorylated p53. At 18h p.i., mock- and MVC-infected cells were collected and analyzed by 
Western blot for p53 phosphorylated at serine 15, p-p53(Ser15). The same membrane was 
reprobed with β-actin. (B) Flow cytometry analysis of the cell cycle. At 18h p.i., mock- or 
MVC-infected cells were incubated with BrdU for 1h. Labeled cells were treated with HCl and 
co-stained with an anti-BrdU antibody and DAPI, and then analyzed by flow cytometry. Numbers 
show percentages of cells in S phase and G2/M phase in each histogram. (C) Southern blot 
analysis of viral DNA repletion. At 18h p.i., mock- or MVC-infected cells were collected at the 
indicated times p.i., and Hirt DNA was extracted for Southern blot analysis. 
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SMC1 plays a key role in MVC infection-induced intra-S phase arrest. 
As a well-established intra-S phase checkpoint protein, SMC1 is a downstream effector 
of the ATM signaling pathway sensed by the MRN complex [163]. We have shown previously 
that the MRN complex was recruited to the viral replication compartments, and that SMC1 was 
phosphorylated at serine 957 during MVC infection [30]. Therefore, we decided to assess the 
role of SMC1 in the MVC-induced intra-S phase arrest.  
We observed that SMC1 was phosphorylated during early infection (Fig. 7A). Next, we 
next knocked down approximately 60% of the endogenous SMC1 (Fig. 7B), at which level the 
regular cell cycle pattern was not altered (Fig. 7C, Mock). Notably, knockdown of SMC1 caused 
a 14, 16, and 20% decrease in the cell population in S phase at 12h, 18h and 24h p.i., 
respectively (Fig. 7C). The cell cycle patterns of SMC1 siRNA (siSMC1)-treated groups at 12h 
and 18h p.i. were close to those of the mock groups. In addition, the reduction in the intra-S 
phase arrest caused by SMC1 knockdown significantly blocked MVC DNA replication (Fig. 7D). 
Collectively, these results strongly suggest that SMC1 plays a key role in inducing the 
intra-S phase arrest during MVC infection, and that repression of viral DNA replication by SMC1 
knockdown is likely the direct outcome of the abrogation of the intra-S phase checkpoint function 
of SMC1. 
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Figure 7. Knockdown of SMC1 blocks MVC infection-induced intra-S phase arrest. 
(A) Western blot analysis of SMC1 expression. WRD cells were infected with MVC. At the 
indicated times pi, the cells were collected and analyzed for expression of SMC1 and 
phosphorylated SMC1 at serine 957, p-SMC1(Ser957). Mock-infected cells were used as a 
control. (B-D) Knockdown of SMC1 reduced cell population in S phase and viral DNA replication. 
WRD cells were transfected with siRNA control (siScrambled) or SMC1 siRNA (siSMC1). At 2 
days post-transfection, the cells were mock- or MVC-infected. At the indicated times p.i., cells 
were analyzed as follows. (B) One third of the cells were collected and analyzed for SMC1 by 
Western blotting. (C) One third of the cells were incubated with BrdU for 1h, denatured by HCl, 
and co-stained with an anti-BrdU antibody and DAPI for flow cytometry analysis. Numbers show 
percentages of the cell population in S phase and G2/M phase, respectively. The statistical 
analysis of the percentage of cells in S phase from three independent experiments is shown. 
Data are shown as mean ± standard deviation. P values were determined using Student’s t-test. 
(D) One third of the cells were collected for Hirt DNA extraction and Southern blot analysis.   
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Phosphorylation of SMC1 at serines 957 and 966 is essential for the intra-S phase arrest 
induced during MVC infection. 
Since phosphorylation of SMC1 at serines 957 and 966 is important for the checkpoint 
function of SMC1 [250], we assessed their role in the intra-S phase arrest induced during MVC 
infection. We observed that phosphorylated SMC1 co-localized with MVC NS1 during early 
infection (Fig. 8A). To test whether SMC1 phosphorylation at serines 957 and 966 is required for 
the intra-S phase arrest, endogenous SMC1 was replaced by ectopic expression of a wild-type 
human SMC1 (hSMC1wt) or hSMC1 mutated at serines 957 and 966. Canine SMC1 mRNA 
(XM_538049.3) and human SMC1 (NM_006306.2) encode an identical SMC1 protein sequence 
[250]. The majority of endogenous SMC1 was complemented by hSMCwt (Fig. 8B, hSMC1wt), 
which nearly fully restored the function of SMC1 in inducing the intra-S phase arrest (Fig. 8C, 
hSMC1wt). A SMC1 protein band, shown by an arrow in Fig. 8B, at a position lower than the size 
of the endogenous SMC1 in transfected cells, is likely an isoform of the transfected human 
SMC1-encoding gene. Notably, while a dominant-negative form of SMC1 [250], termed 
hSMC1(S957A/S966A), was used to complement the lack of endogenous SMC1 in SMC1-knockdown 
cells, it was able to block approximately 17% of the cell population in S phase (Fig. 8C), 
indicating that the intra-S phase arrest is blocked by this dominant-negative mutant. Thus, these 
results suggest that the phosphorylation of SMC1 at serines 957 and 966 is necessary for the full 
function of SMC1 as an intra-S phase checkpoint during MVC infection. 
       Taken together, our results provide evidence that replication of MVC triggers SMC1 
phosphorylation, which functions as a checkpoint protein to induce the intra-S phase arrest of the 
host cells.   
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Figure 8. Complementation of endogenous SMC1 with an SMC1 dominant-negative 
mutant (hSMC1(S957A/966A)) rescues MVC infection-induced intra-S phase arrest. 
(A) Immunofluorescence analysis of SMC1 phosphorylation. WRD cells were seeded on 
chamber slides 24h prior to MVC infection. At 18h p.i., cells were fixed and co-stained with an 
anti-MVC NS1 antibody, an anti-p-SMC1(Ser957) antibody and DAPI. Confocal images were 
taken at a magnification of ×100. Mock-infected cells were used as a negative control. (B-D) 
Analysis of SMC1 complementation with hSMC1(S957A/S966A) on the cell cycle. WRD cells were 
transfected twice with siScrambled or siSMC1 siRNA, and subsequently transfected with an 
empty vector, a plasmid expressing wild-type human SMC1A (hSMC1wt) or dominant-negative 
mutant hSMC1(S975A/S966A). (B) At 24h post-transfection, cells were collected and analyzed by 
Western blotting using an anti-SMC1 antibody. The same membrane was reprobed for β-actin. 
Arrow shows a potential isoform of human SMC1. (C) At 24h post-transfection, cells were 
infected with MVC or mock-infected. Infected cells were incubated with BrdU for 1h at 18h p.i. 
Then cells were collected, treated with HCl, and co-stained with an anti-BrdU antibody and DAPI 
for cell cycle analysis by flow cytometry. Numbers shown in each histogram are percentages of 
the cell population in S phase and G2/M phase, respectively, as indicated. (D) The statistical 
analysis of the percentage of cells in S phase, performed from three independent experiments, is 
shown. Data are shown as mean ± standard deviation. P values were determined using 
Student’s t-test. 
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Replicating viral genome, but not damaged cellular DNA, induces intra-S phase arrest 
during MVC infection. 
Previous studies of DDR induced by autonomous parvoviruses, MVC, MVM, and B19V 
have demonstrated that viral DNA replication, but not individual viral protein, triggers a DDR 
[29,30,101]. To further examine the cause of MVC infection-induced DDR, we asked whether 
virus infection is able to cause cellular DNA damage. To this end, we performed a Comet assay, 
which is commonly used for the detection of both DSBs and SSBs of chromosome DNA 
[265–268]. H2O2 treatment, as a control, was able to cause severe damage to cellular DNA as 
shown by the fact that nearly all the cells were Comet-positive (DNA-damaged); however, neither 
mock- nor MVC-infected cells contained Comet-positive cells (Fig. 9A). These results suggest 
that the DDR signaling induced during MVC infection comes from viral DNA or its replicative 
intermediate molecules, rather than from cellular DNA. 
To determine whether viral DNA replication is required for the intra-S phase arrest 
induced during early infection, we transfected cells with a wild-type infectious clone of MVC 
(pIMVC) and its derivative mutants, pMVC(NSCap), or pIMVC(NP-) and pIMVC(VP1/2-), which 
do not have the terminal hairpins or express NP1 and capsid proteins, respectively [118,119]. 
pMVC(NSCap) does not replicate but expresses all viral proteins, pIMVC(NP-) replicates very 
poorly (approximately 50-fold decrease compared with the wild-type), and pIMVC(VP1/2-) 
replicates at an intermediate level without production of ssDNA [30,118]. In addition, NS1 and 
NP1 (Flag-tagged) were expressed individually. Transfected cells were selected by either NS1 or 
Flag-tag and analyzed for the cell cycle pattern. Most of the cells transfected with pIMVC and 
pIMVC(VP1/2-), which replicate viral DNA, were accumulated in S phase, while cells transfected 
with other plasmids that were replication-incompetent or inefficient [118], failed to arrest cells in S 
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phase, though viral proteins were expressed (Fig. 9B). These results indicate that the replicating 
viral genome, but not viral proteins, was the cause of the intra-S phase arrest. 
The MRN complex is not only the sensor of DDR, but also the initiator of the ATM-SMC1 
signaling-induced intra-S phase arrest [36,163,250]. We hypothesized that the replicating viral 
DNA is likely sensed by the MRN complex as damaged DNA, which activates the DDR signaling 
and thereafter the intra-S phase arrest. To prove this, we checked the localization of the MRN 
complex in the nuclei of MVC-infected cells. At 18h p.i., a time point at which MVC DNA actively 
replicates, Mre11, Rad50 and phosphorylated NBS1 (p-Nbs1) all co-localized within the viral 
DNA replication centers as shown with anti-BrdU staining (Fig. 9C). Furthermore, we performed 
a BrdU-IP assay to determine whether the newly synthesized viral ssDNA/intermediates was 
associated with the MRN complex. Notably, we were able to precipitate Mre11, the DNA binding 
component of the MRN complex [269], from BrdU-incorporated MVC-infected cells but not from 
mock-infected cells (Fig. 9D, lane 4). 
Collectively, we have provided evidence that cellular DNA is not damaged in 
MVC-infected cells, and that the viral DNA replication process is critical for the intra-S phase 
arrest induced during MVC infection. More importantly, the replicating viral DNA is able to mimic 
damaged cellular DNA, perhaps due to aberrant DNA structures, to recruit the MRN complex, 
which in turn activates ATM signaling and initiates the intra-S phase arrest. 
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Figure 9. MVC infection-induced DDR and intra-S phase arrest are dependent on 
replicating viral DNA.  
(A) Comet assay analysis. WRD cells were mock- or MVC-infected. At 18h p.i., half of the 
cells were collected and analyzed by Comet assay; the other half of the cells were fixed and 
co-stained with an anti-NS1 antibody and DAPI to quantify the percentage of infected (NS1+) 
cells by immunofluorescence analysis. Confocal images were taken at a magnification of ×40. A 
statistical analysis of the percentage of cells with damaged DNA was performed from three 
independent Comet assays. Data are shown as mean ± standard deviation. (B) Flow cytometry 
analysis of the cell cycle in transfected cells. WRD cells were transfected with the indicated 
plasmids for 18h, and then were incubated with BrdU for 1h. The cells were collected, treated 
with HCl and co-stained with DAPI, anti-BrdU and anti-NS1 antibodies (for pIMVC and mutant 
derivatives) or an anti-Flag antibody (for pLenti-based plasmids) for flow cytometry analysis. 
(C&D) The MRN complex is associated with replicating viral DNA. Mock- or MVC-infected cells 
were incubated with BrdU for 1h at 18h p.i. (C) Immunofluorescence analysis of the MRN 
complex. The cells were fixed and co-stained with the indicated antibodies and DAPI. Confocal 
images were taken at a magnification of ×100. (D) Co-immunoprecipitation with an anti-BrdU 
antibody. The BrdU-labeled cells were lysed and centrifuged. The supernatant containing 
BrdU-labeled viral genome was immunoprecipitated with an anti-BrdU antibody.  
Immunoprecipitated samples were blotted with an anti-Mre11 antibody. An amount of lysate 
equal to 5% was used as an input control for each sample. Arrows show Mre11 bands, whereas 
arrowheads show the immunoprecipitated light and heavy chains of the IgG antibody.         
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 Discussion 
This study demonstrated that autonomous parvovirus infection induces the intra-S phase 
arrest to delay S phase progression and to hijack cellular DNA replication factors for viral DNA 
replication. The intra-S phase arrest is mediated by ATM signaling through phosphorylation of 
SMC1. The study also provided evidence that the autonomous parvovirus infection-induced DDR 
is elicited by replicating viral DNA, which is sensed by the MRN complex. Thus, our study 
provides, for the first time, a novel DNA replication model for autonomous parvovirus (Figure 10). 
In this model, MVC DNA replication triggers intra-S phase arrest through the 
MRN-ATM-SMC1 pathway. The replicating viral DNA mimics damaged DNA that is sensed by 
the MRN complex. The intra-S phase arrest blocks cellular DNA synthesis and therefore 
prolongs   S phase in infected cells, presumably through degradation or transcriptional 
regulation of DNA replication factors. By contrast, the MRN complex may coordinate DNA 
replication and repair factors through SMC1 activation to facilitate viral DNA synthesis. The 
feedback loop between viral DNA replication and the intra-S phase arrest plays an essential role 
in modulation of the cellular environment by MVC to make it conducive to viral DNA replication. 
One of the important findings of our study is that S phase is required but not sufficient for 
autonomous parvovirus replication. It has been reported that DNA replication of MVM is strictly 
dependent on cellular factors expressed during S phase [9,11,111]. The basic replication 
machinery components, such as PCNA, RPA, pol α, pol δ, and cyclin A, all co-localized within 
the autonomous parvovirus-associated replication (APAR) bodies [111,263]. In vitro studies 
indicated that the cyclin A level directly affects MVM DNA replication efficiency [13] and that 
PCNA, RPA, and pol δ are essential for MVM DNA replication [171,270]; however, like many 
other DNA viruses, autonomous parvovirus infection blocks cellular DNA synthesis 
[8,16,17,113,271], which was thought to be due to competition for access to the cellular 
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replication machinery by viral DNA replication [8,271]. Hence, the S phase is essential for 
autonomous parvovirus DNA. Here we show that MVC DNA replicates poorly in ATM-specific 
inhibitor-treated cells which have normal S phase progression (Figure 4). Thus, we provide 
evidence that S phase is not sufficient for autonomous parvovirus DNA replication. We conclude 
that, in addition to the requirement that infected cells be in S phase, which supplies DNA 
replication factors, the intra-S phase arrest is necessary for autonomous parvovirus to compete 
with cellular DNA synthesis for its own DNA replication. We hypothesize that it is likely that the 
intra-S phase arrest facilitates the recruitment of replication factors through a DNA repair 
pathway, since intra-S phase coordinates DNA repair following DDR induced by damaged 
cellular DNA [143,145] as well as restarts DNA replication forks [242].  
Inhibition of cellular DNA replication is a common strategy for DNA viruses to modulate 
the host cellular environment to make it conducive to viral DNA replication. The inhibition 
processes are often regulated by viral proteins that target the cellular DNA replication machinery. 
For instance, via viral protein pUL117, human cytomegalovirus (HCMV) blocks host DNA 
synthesis by delaying the accumulation of the mini-chromosome maintenance (MCM) complex 
proteins onto chromatin [255]. Human papillomavirus (HPV) inhibits host DNA replication by viral 
early protein E4-mediated suppression of cellular replication origin licensing [254]; however, 
polyomaviruses take advantage of DDR signaling to block cellular DNA synthesis. SV40 infection 
uses the ATR-Δp53-p21 pathway to down-regulate cyclin A-CDK2/1 activity, which forces the 
host to remain in S phase [272]; whereas polyomavirus strain RA has been shown to utilize 
ATM-SMC1 signaling to override cell cycle regulation and prolong S phase [186]. As a result, 
viral infection-triggered intra-S phase arrest slowed down cellular DNA synthesis; however, the 
intra-S phase arrest induced by polyomaviruses is largely regulated by the viral large T antigen 
[186,199,234,273]. In contrast, none of the MVC-encoded proteins are involved in cell cycle 
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regulation [121] (Figure 8). Therefore, we have identified, for the first time, a viral DNA 
replication-dependent intra-S phase arrest that is ATM-mediated. 
The ATM-SMC1 pathway is intimately involved in slowing down the cellular DNA 
replication rate in response to DSBs [145]; however, how phosphorylated SMC1 interferes with 
cellular DNA replication remains unclear. At least in MVC infection-induced intra-S phase arrest, 
RFC1, which is a key component of the RFC complex that loads PCNA to replicating DNA 
[274,275], is a major target for down-regulation (Figure 3). Notably, during the very early phase 
of infection, RFC1 co-localized within the viral replication centers, and later disappeared from the 
centers when viral DNA was actively replicating. This led to hypothesize that RFC1 is required for 
the conversion of viral ssDNA to the double-stranded replicative form (RF DNA) (Figure 9, Step 
1) upon virus infection. Nevertheless, the down-regulation of RFC1 during the intra-S phase 
arrest provides a candidate for linking SMC1 activation with down-regulation of cellular DNA 
replication. The function of RFC1 in MVC DNA replication and in SMC1-mediated intra-S phase 
arrest warrants further investigation.      
Studies on virus infection-induced DDR have uncovered novel mechanisms underlying 
viral-host interaction [49,81]. Although early studies indicated that infection of most DNA viruses 
was able to create lesions on cellular DNA involving viral proteins [113,199,276–279], whether 
this is common and the major cause of the activation of DDR signaling is not clear. Our study has 
shown that MVC infection did not cause obvious damage to cellular DNA (Figure 8), hence the 
DNA damage signaling induced during MVC infection must come from viral DNA. We and others 
previously have shown that replication of autonomous parvovirus is required for triggering a DDR 
[29,30,101]. Here, we provide evidence, for the first time, that replicating viral genomes (or 
intermediates), mimic damaged cellular DNA (likely DSBs), which, in the case of autonomous 
parvovirus, likely involves the unique hairpin structures, thereby recruiting the MRN complex and 
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DDR proteins. However, due to the difficulty to isolate such intermediate DNA, we are not able to 
provide direct evidence to show that such DNA structures can directly induce DDR signaling. 
Nevertheless, in addition to the fact that the DNA damage sensor, the MRN complex, is directly 
associated with the replicating viral DNA, Nbs1 was phosphorylated in the viral replication 
centers (Figure 8), strongly suggesting that a DNA repair pathway followed by intra-S phase 
arrest is involved in MVC DNA replication. Interestingly, accumulating evidence has shown that 
DNA repair factors are localized in the replication compartments of many DNA viruses, for 
instance the homologous recombinational repair (HRR) factors are recruited into the replication 
centers of EBV, SV40, and HPV [173,199,235]. It was suggested that HRR factors might be 
recruited to repair DSBs on the viral genome in the viral replication compartments, but not for 
viral DNA replication. It is understandable that the DSB-initiated repair pathways of homologous 
recombination of nonhomologous end joining (NHEJ) are involved in the replication of DNA 
viruses whose genome is dsDNA since their replication often involves a step of circularization; 
however, DNA replication of autonomous parvoviruses, whose genome is ssDNA, follows a 
rolling-hairpin strategy of DNA replication which does not involve circularization of any replication 
intermediates [114]. The fact that SMC1, a cohesion protein of chromosome DNA, plays a key 
role in MVC DNA replication may also suggest that it maintains proper alignment of the 
parvoviral minichromosome [280,281] for terminal resolution of RF DNA [114], in addition to its 
role in the intra-S phase arrest. How these DNA repair factors accumulated in the viral replication 
centers facilitate viral DNA replication, in particular during autonomous parvovirus infection, 
remains unknown and is a central question in parvovirus DNA replication. 
In summary, MVC infection triggers a MRN-ATM-SMC1-mediated intra-S phase arrest to 
create an S phase environment and to recruit the cellular DNA replication machinery, and 
perhaps the DNA repair machinery, to facilitate MVC DNA replication. Such a strategy may 
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represent a common feature of the DDR induced by many small DNA viruses, which are 
dependent on S phase for replication in host cells.   
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Figure 10. A proposed model for autonomous parvovirus DNA replication in the context of 
the intra-S phase arrest.  
The proposed pathways utilized by autonomous parvovirus during replication are 
described in detail in the Discussion section. The question mark indicates steps not well 
understood.  
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Chapter 5 
 
 
Conclusions and Discussion 
 
Parvoviruses are widespread in different species and induce highly contagious diseases 
[1,2]. Human parvovirus B19V and HBoV1 are pathogens of life-threatening human diseases 
[124,230,231]. Unfortunately, there is currently no treatment for parvovirus infection-induced 
human diseases. Study of parvovirus infection-induced DDR has not only greatly improved our 
understanding of the basic replication mechanism of parvovirus, but has also revealed potential 
targets for the treatment of parvovirus-caused diseases. Moreover, parvovirus is the only virus 
type to introduce linear ssDNA into the host cell nucleus, therefore it is a unique in vivo model 
system to probe the mechanism of exogenous ssDNA-induced DDR. 
Different parvovirus infection triggers different DDR signaling pathways. Both MVM and 
MVC activate the ATM signaling during their early and late stages of infection [29,30,112]. By 
contrast, B19V infection elicits a robust DDR with all the three PI3KKs phosphorylated [28]. The 
difference is likely due to their different genome structures and their host cells. Both MVM and 
MVC have asymmetric terminal repeats, which are different from those of B19V. The ITRs of 
B19V are similar to that of AAV2, which also triggers ATR activation when it is inactivated by UV 
[78,79]. Coinfection of AAV2 and HSV-1 also induces phosphorylation of all the three PI3KKs, 
although it is difficult to differentiate which pathway is activated by replication of AAV2 alone [69], 
since HSV-1 also interplays with the DDR machinery [71–73]. Moreover, the cell cycle pattern of 
B19V-infected cells differs from that of MVM- or MVC-infected cells. During early infection, MVM 
and MVC create a prolonged S phase environment to facilitate viral DNA replication 
[11,12,17,111,114]. By contrast, following B19V infection, infected cells quickly accumulated at 
the phase that had a 4N DNA content [15,18,100,101,282], which could be due to an arrest at 
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late S phase or G2/M phase. Such a difference in arresting the host cell cycle may result in 
activation of different DDR pathways [47]. 
Our study of MVC infection-induced DDR has revealed a novel model for parvovirus DNA 
replication. Early in vivo and in vitro studies of MVM DNA replication has indicated that S phase 
is required for parvovirus DNA replication [8–14], while some studies also noticed that the 
cellular replication rate is significantly reduced during parvovirus infection [16,17,113], indicating 
that a strategy is required for parvovirus to compete with host cellular DNA replication. Indeed, 
we observed that S phase is required but not sufficient for MVC DNA replication [30]. Treatment 
of an ATM-specific inhibitor did not perturb regular S phase progression, but significantly blocked 
viral DNA replication, suggesting that an ATM-dependent mechanism is essential to create a 
favorable microenvironment for MVC genome amplification. Further study demonstrates that 
MVC infection triggers an intra-S phase arrest that is dependent upon the ATM-SMC1 signaling 
pathway. The intra-S phase arrest not only blocks cellular DNA replication, but also delays S 
phase progression. Therefore, in the context of the intra-S phase arrest, MVC represses cellular 
DNA replication and continuously hijacks cellular DNA replication machinery. These findings 
have revealed the beneficial effects of the ATM activation on autonomous parvovirus DNA 
replication, and suggest a novel model for parvovirus DNA replication. Since the MVC genome 
shares 50-60% identity with HBoV1 [119], our study may also shed light on the HBoV1 
replication mechanism as well as viral pathogenesis. 
The parvovirus genome has the intrinsic ability to induce a DDR. Unlike many large DNA 
viruses which encode multiple viral proteins to interact with host cells, parvovirus only encodes 
2-3 nonstructural proteins. The largest non-structural proteins of parvoviruses are conserved and 
essential for viral DNA replication. Although in some studies, the largest non-structural proteins 
have been shown to cause non-specific nicking of cellular DNA [10,65,113] , this is neither the 
 
144 
 
major cause of the DDR activation nor the driving force of S phase arrest, since the majority of 
the largest non-structural proteins colocalize with the viral DNA genome during active viral 
replication. In concert, expression of the MVC non-structural proteins failed to perturb the cell 
cycle pattern and induce a DDR [30,121]. As exogenous DNA, parvoviral genomes are aberrant 
from any cellular DNA structure. Our study indicates that the replicating MVC genome is 
associated with the MRN complex, which is not only the sensor for the activation of the ATM 
signaling, but also the initiator for the recruitment of many DNA repair factors [36,163,250]. It is 
likely that the MRN complex initially functions as an anti-virus device, as evidenced during 
coinfection of AAV with helper adenovirus [57]. However, this device is either destroyed by AAV 
through its helper virus [57], or hijacked for viral DNA replication during MVM and MVC infection 
[29,30]. The intra-S phase arrest also has a potential role to recruit DNA repair factors into the 
viral replication centers, resulting in a repair-dependent replication of parvovirial DNA 
[145,242,248]. Whether any downstream DNA repair factors of the MRN complex are recruited in 
the parvovirus DNA replication centers awaits further investigation. 
Parvovirus infection-induced DDR contributes to viral infection-induced apoptosis. 
Parvovirus infection-induced cell death is directly associated with viral pathogenesis, e.g., 
hemolytic anemia caused by apoptosis of erythroid-lineage cells upon B19V infection [283,284]. 
Although several studies have revealed that non-structural proteins of parvoviruses, such as 
NS1 and 11-kDa proteins of B19V are able to trigger apoptosis [19,95,96], ectopical expression 
of individual non-structural proteins of MVC did not induce obvious cytopathic effects [121]. The 
role of DDR in apoptosis has been widely documented [39,227]. p53 plays a central role in 
coordinating DDR-induced cell cycle arrest, gene transcription and apoptosis [285]. Driven by the 
ATM kinase, p53 is phosphorylated at serine15 and 46, protecting p53 from the degradation by 
its negative regulator MDM2 [286,287]. The p53 protein regulates apoptosis through competition 
with DNA repair proteins for binding to exposed single-stranded regions of damaged DNA, and 
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transactivation of proapoptotic genes [288]. During infection of MVM, MVC and B19V, 
phosphorylation of p53 at serine 15 was observed [29,30,101]. However, p53 does not have a 
direct role in inducing cell cycle arrest during infection of these three viruses. Instead, knockdown 
of phosphorylated p53 during the late stage of MVC infection significantly blocked MVC 
infection-induced cell death [30]. Since our previous study has confirmed that MVC infection 
triggers a mitochondrion-mediated apoptosis [121], we conclude that MVC infection-induced cell 
death is regulated by the ATM-p53 mediated apoptosis. This observation has revealed a new 
strategy of parvovirus-induced cell death, which is critical for viral pathogenesis. Further studies 
are warranted to discern whether phosphorylation of p53 affects MVM and B19V 
infection-induced cell death. 
Study of B19V infection-induced DDR has advanced our understanding of the B19V DNA 
replication mechanism as well as B19V infection-induced cell cycle arrest. As it is difficult to 
study B19V in human primary erythroid progenitor cells, very few cellular factors have been 
found to be involved in B19V DNA replication. We have identified that all three PI3KKs, along 
with many downstream effectors, co-localized to with the B19V replication centers [28]. More 
importantly, the ATR and DNA-PKcs signaling pathways contribute to B19V DNA replication 
through unclear mechanisms. The ATR signaling phosphorylates a number of proteins such as 
MCM (mini-chromosome maintenance proteins), RPA, PCNA and several DNA polymerases, to 
resume the replication of stalled replication forks [217]. Whether those downstream substrates of 
the ATR signaling are recruited to the B19V replication centers has not been studied. 
Surprisingly, although two checkpoint kinases, Chk1 and Chk2, were phosphorylated and 
co-localized with B19V replication centers, inhibition of them did not affect B19V 
infection-induced G2/M arrest [28]. By contrast, G2/M arrest turns out to be a direct outcome of 
B19V NS1 protein expression, which deregulates the E2F family of transcription factors [100]. 
The function of G2/M arrest during B19V infection is a mystery, since many other parvoviruses 
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take advantage of S phase arrest for productive virus infection [8–14]. It would be valuable to 
know whether the DDR signaling contributes to S phase (late S phase with a 4N DNA content) 
arrest during B19V infection. 
Taken together, by using parvovirus as a model organism, we have probed the basic 
mechanism of the DDR induced by aberrant ssDNA. Our findings have greatly facilitated the 
understanding of the mechanism of parvovirus DNA replication, and have revealed new 
strategies by which parvovirus induces host cell cycle arrest and apoptosis. Our study also sheds 
light on the mechanisms by which other small DNA viruses induce a DDR. More importantly, our 
study will facilitate the identification of efficient anti-viral targets for the treatment of 
parvovirus-caused diseases. 
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